Dental photocurable composition having excellent color tone selectivity

By using a combination of α-dione compounds, aryliodonium salts and specific photopolymerization accelerators in dental photocurable compositions, the problems of poor tone and mechanical strength of dental photocurable compositions are solved, and the problem of poor tone and mechanical strength of dental photocurable compositions is achieved. Improved tone consistency and mechanical performance.

CN113402666BActive Publication Date: 2024-11-15SHOFU INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110277946.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-03-12
Filing Date
2021-03-15
Publication Date
2024-11-15
Estimated Expiration
2041-03-15

Smart Images

  • Figure BDA0002977385270000321
    Figure BDA0002977385270000321
  • Figure BDA0002977385270000322
    Figure BDA0002977385270000322
  • Figure BDA0002977385270000323
    Figure BDA0002977385270000323
Patent Text Reader

Abstract

The present invention provides a dental photocurable composition having sufficient mechanical properties, small color difference before and after curing, and excellent color selectivity. The dental photocurable composition of the present invention is a dental photocurable composition comprising (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler, wherein the (B) photosensitizer comprises a (B-1) α-diketone compound, and relative to 100 parts by mass of the (A) polymerizable monomer, contains 0.15 parts by mass of the following (B-1) α-diketone compounds, 0.5 parts by mass or more of the (C) photoacid generator, and 100 parts by mass or more of the (E) filler.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a photocurable composition for dental use. Background Art

[0002] In the dental field, dental photocurable compositions are used, which are applied to dental adhesives, dental composite resins, dental abutment repair materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials (Dental Manicure material), dental loose tooth fixing adhesives, dental glass ionomer cements, dental hard resins, dental cutting materials, dental 3D printing materials, etc.

[0003] Japanese Patent Nos. 4093974 and 4596786 propose, as a photopolymerization initiator, a photopolymerization initiator comprising a photoacid generator (a triazine compound or a specific aryliodonium salt), a sensitizer, and an electron donating compound.

[0004] Japanese Patent No. 5114498 proposes a two-component dental cement in which the amount of α-diketone compounded is limited. Summary of the invention

[0005] However, these dental photocurable compositions have a large difference in color tone before and after curing, and it is difficult to select an appropriate color tone based on the color tone of the dental photocurable composition before curing. When the amount of photosensitizer is reduced in order to reduce the color tone difference before and after curing, it is difficult to express sufficient mechanical properties.

[0006] An object of the present invention is to provide a dental photocurable composition having sufficient mechanical properties, small color difference before and after curing, and excellent color tone selectivity.

[0007] The dental photocurable composition of the present invention is a dental photocurable composition comprising (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler, wherein the (B) photosensitizer comprises a (B-1) α-diketone compound, and the composition contains 0.15 parts by mass or less of the (B-1) α-diketone compound, 0.5 parts by mass or more of the (C) photoacid generator, and 100 parts by mass or more of the (E) filler, based on 100 parts by mass of the (A) polymerizable monomer.

[0008] The dental photocurable composition of the present invention has sufficient mechanical properties, small color difference before and after curing, and excellent color tone selectivity. DETAILED DESCRIPTION

[0009] In the present invention, the (B-1) α-diketone compound may be a camphorquinone compound.

[0010] In the present invention, (C) the photoacid generator includes an aryl iodonium salt, and the aryl iodonium salt may be a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga, and an aryl iodonium cation.

[0011] In the present invention, the photoacid generator (C) includes an aryl iodonium salt, which can be a salt of an organic group having at least one H substituted by F and an anion of any one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation.

[0012] In the present invention, (D) the photopolymerization accelerator may include (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.

[0013] In the present invention, 1 part by mass or more of the (C) photoacid generator and 0.5 parts by mass or more of the (D) photopolymerization accelerator may be contained based on 100 parts by mass of the (A) polymerizable monomer.

[0014] In the present invention, the difference between the b* before curing when the hue of the dental photocurable composition (when the dental photocurable composition contains a pigment, it is the dental photocurable composition excluding the pigment) is measured on a white background with a thickness of 1 mm in the L*a*b* space and the b* before curing when the hue of the cured body of the dental photocurable composition is measured on a white background with a thickness of 1 mm in the L*a*b* space can be 5 or less.

[0015] In the present invention, the single-component dental photocurable composition contains 0.005 to 0.15 parts by mass of (B-1) α-diketone compound, 0.5 to 10 parts by mass of (C) photoacid generator, 0.1 to 10.0 parts by mass of (D) photopolymerization accelerator, and 150 to 1000 parts by mass of (E) filler, relative to 100 parts by mass of (A) polymerizable monomer.

[0016] In the present invention, it can be a two-component dental photocurable composition, which is composed of a first paste and a second paste, wherein the first paste contains a first matrix containing (A) a polymerizable monomer, (B-1) an α-diketone compound, (C) a photoacid generator, and (D) a photopolymerization accelerator, and (E) a filler, and the second paste contains a second matrix containing (A) a polymerizable monomer, (B-1) an α-diketone compound, (C) a photoacid generator, and (D) a photopolymerization accelerator, and (E) a filler, and the ratio of the first paste to the second paste is 1:0.8 to 1.2, and the first paste contains 0.01 to 0.3 parts by mass of the (B-1) α-diketone compound, 1.0 to 20.0 parts by mass of the (C) photoacid generator, 0.2 to 20.0 parts by mass of the (D) photopolymerization accelerator, and 200 to 800 parts by mass of the (E) filler, relative to a total of 200 parts by mass of the (A) polymerizable monomer contained in the first matrix and the second matrix.

[0017] The dental photocurable composition of the present invention is used in combination with a dental composition for checking the uniformity of color tone to constitute a dental kit.

[0018] Hereinafter, each component of the dental photocurable composition of the present invention is described in detail. The dental photocurable composition of the present invention is used as a dental adhesive material, a dental composite resin, a dental abutment repair material, a dental resin cement, a dental coating material, a dental pit and fissure sealing material, a dental cosmetic material, a dental loose tooth fixing adhesive material, a dental glass ionomer cement, a dental hard resin, a dental cutting material, a dental 3D printing material, and the like.

[0019] In dental clinics, in order to restore the aesthetic and functional properties of missing teeth caused by caries or fractures, direct restoration with dental composite resins or indirect restoration of prosthetic devices made of ceramics or dental hard resins with dental resin cements is performed. In addition, dental adhesive materials for bonding dental composite resins to various dental materials and natural teeth, dental loose tooth fixing adhesive materials for fixing loose teeth, dental coating materials for protecting hypersensitive or formed vital pulp teeth from external stimulation or secondary caries, dental pit and fissure sealing materials for preventing caries by filling complex grooves of deciduous teeth, dental cosmetic materials for temporarily restoring aesthetics by masking tooth discoloration, and dental abutment construction materials for forming abutment teeth when the crown of a tooth collapses due to caries have been developed in recent years. New composite materials such as dental cutting materials for making prosthetic devices by CAD / CAM processing and dental 3D printing materials for making prosthetic devices by 3D printing have been developed, and various dental materials are used for treatment. The above-mentioned materials are mixed with a resin matrix composed of several polymerizable monomers, various fillers such as inorganic fillers or organic-inorganic composite fillers, and a polymerization initiator according to their uses to prepare a uniform paste. Taking some materials as an example, a dental filling composite resin is filled into a tooth in the state of an uncured paste, and after being given the anatomical form of a natural tooth using a dental appliance such as an instrument, it is used by curing it by irradiating light using a dental light irradiator. The irradiation light from the light irradiator is generally used in the wavelength range of about 360 to 500 nm and the light intensity is 100 to 2000 mW / cm 2 On the other hand, when bonding a prosthetic device to a cavity or abutment, a dental resin cement is used, and after the prosthetic device is attached to the cavity or the abutment, light is irradiated and cured.

[0020] As a photopolymerization initiator for such dental materials, a photosensitizer or a system in which a suitable photopolymerization accelerator is combined with a photosensitizer is widely used. As photosensitizers, acylphosphine oxide compounds or α-diketone compounds are known, and α-diketone compounds in particular have polymerization initiation ability in the visible light wavelength region that has little effect on the human body. In addition, α-diketone compounds have photobleaching ability, and since the yellow color as the original color tone disappears after light irradiation, the color tone affinity for white tooth texture is particularly high.

[0021] Tertiary amine compounds are well known as polymerization accelerators in combination with photosensitizers. Since the combination of α-diketone compounds and tertiary amine compounds has high polymerization activity to irradiated light, they are used in the field of dental materials. Dental photocurable compositions containing such photopolymerization initiators exhibit excellent mechanical properties such as hardness, bending strength, and compressive strength required of various materials.

[0022] However, the conventionally used photopolymerization initiators have a large amount of photosensitizers, so there is a problem of different tones before and after curing. For example, when filling composite resins, it is difficult to imagine the color tone after curing, so there is a risk that the surgeon will make a mistake in color tone selection, or when the dental photocurable composition filled deep into the cavity is unevenly cured, the color tone consistency becomes insufficient.

[0023] In addition, for dental cement, in cases requiring high aesthetics such as cases using prosthetic devices or laminated veneers made of ceramics, a trial paste can be used in combination. By using it in the trial (trial) stage, the color tone of the prosthetic device or dental cement to be finally used is selected. Since the trial paste is used to confirm the final bonding state of the prosthetic device, it can be made into the same color tone as the dental photocurable composition after curing. Therefore, in the case where the color tone before the dental photocurable composition is cured is different from the color tone after curing, similarly, due to the different color tone from the trial paste, there is a situation where the surgeon mistakenly recognizes the color tone selection error.

[0024] Thus, for example, in conventional photopolymerization initiator systems, by reducing the amount of photosensitizer incorporated, the change in color tone before and after curing can be reduced. However, in this case, curing does not proceed sufficiently, and it is difficult to develop sufficient mechanical strength to withstand use as a dental material.

[0025] To solve the above problems, the present inventors have found that the dental photocurable composition of the present invention reduces the amount of α-diketones as photosensitizers to a smaller amount than before, and can obtain good mechanical properties by combining a photoacid generator and a photopolymerization accelerator, thereby completing the present invention. That is, when using the dental photocurable composition of the present invention, the surgeon can easily imagine the color tone after curing from the stage before light irradiation, and can expect to express excellent color tone consistency for teeth. In addition, since the color tones of the dental photocurable composition and the trial paste before and after curing are the same, it can be expected that the use of these combined dental cement kits can reduce the surgeon's error in color tone selection.

[0026] The (A) polymerizable monomer of the present invention can be used without limitation as long as it is a known substance. Among the polymerizable monomers or compounds having polymerizable groups described in the present invention, polymerizable groups that exhibit free radical polymerizability are preferred. Specifically, from the viewpoint of easy free radical polymerization, the polymerizable groups are preferably (meth) acrylic acid groups and / or (meth) acrylamide groups. It should be noted that in this specification, "(meth) acrylic acid" refers to acrylic acid and / or methacrylic acid, "(meth) acryloyl" refers to acryloyl and / or methacryloyl, "(meth) acrylate" refers to acrylate and / or methacrylate, and "(meth) acrylamide" refers to acrylamide and / or methacrylamide. It is also possible to preferably use polymerizable monomers having a substituent at the α position of the acrylic acid group and / or acrylamide group. There are substances having one free radical polymerizable group, substances having two free radical polymerizable groups, substances having three or more free radical polymerizable groups, substances having acidic groups, substances having alkoxysilyl groups, substances having sulfur atoms, and the like.

[0027] Specific examples of the polymerizable monomer having one radical polymerizable group and no acidic group include 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, 10-hydroxydecyl (meth)acrylate, propylene glycol mono (meth)acrylate, glycerol mono (meth)acrylate, erythritol mono (meth)acrylate, N-hydroxymethyl (meth)acrylamide. , N-hydroxyethyl (meth)acrylamide, N,N-(dihydroxyethyl) (meth)acrylamide, methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate, benzyl (meth)acrylate, lauryl (meth)acrylate, 2,3-dibromopropyl (meth)acrylate, 3-(meth)acryloxypropyltrimethoxysilane, 11-(meth)acryloxyundecyltrimethoxysilane, (meth)acrylamide, etc.

[0028] Specific examples of the polymerizable monomer having two free radical polymerizable groups and no acidic group include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy)-2-hydroxypropoxyphenyl]propane (commonly referred to as "Bis-GMA"), 2,2-bis(4-(meth)acryloyloxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxy)-2-hydroxypropoxyphenyl)propane, and 2,2-bis(4-(meth)acryloyloxy)-2-hydroxypropoxyphenyl)propane. acryloyloxytetraethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydipropoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxydiethoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxyditriethoxyphenyl)propane, 2-(4-(meth)acryloyloxydipropoxyphenyl)-2-(4-(meth)acryloyloxy triethoxyphenyl)propane, 2,2-bis(4-(meth)acryloxypropoxyphenyl)propane, 2,2-bis(4-(meth)acryloxyisopropoxyphenyl)propane, 1,4-bis(2-(meth)acryloxyethyl)pyromellitic acid ester, glycerol di(meth)acrylate, 1-(acryloxy)-3-(methacryloxy)-2-propanol, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butanediol di(meth)acrylate, Neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (commonly known as "UDMA"), 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and the like.

[0029] Specific examples of the polymerizable monomer having three or more free radical polymerizable groups and having no acidic group include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate, and 1,7-diacryloyloxy-2,2,6,6-tetraacryloyloxymethyl-4-oxyheptane.

[0030] The polymerizable monomer having an acidic group can be used without limitation as long as it has at least one polymerizable group and at least one acidic group such as a phosphate group, a pyrophosphate group, a thiophosphate group, a phosphonic acid group, a sulfonic acid group, or a carboxylic acid group.

[0031] Specific examples of the polymerizable monomer having a phosphate group include 2-(meth)acryloyloxyethyl dihydrogen phosphate, 3-(meth)acryloyloxypropyl dihydrogen phosphate, 4-(meth)acryloyloxybutyl dihydrogen phosphate, 5-(meth)acryloyloxypentyl dihydrogen phosphate, 6-(meth)acryloyloxyhexyl dihydrogen phosphate, 7-(meth)acryloyloxyheptyl dihydrogen phosphate, 8-(meth)acryloyloxyoctyl dihydrogen phosphate, 9-(meth)acryloyloxynonyl dihydrogen phosphate, 10-(meth)acryloyloxydecyl dihydrogen phosphate, 11-(meth)acryloyloxyundecyl dihydrogen phosphate, 12-(meth)acryloyloxydodecyl dihydrogen phosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen phosphate, 20-(meth)acryloyloxyeicosyl dihydrogen phosphate, bis[2-(meth)acryloyloxyethyl] hydrogen phosphate, bis[4-(meth)acryloyloxybutyl] hydrogen phosphate, bis[6-(meth)acryloyloxyhexyl] hydrogen phosphate, bis[8-(meth)acryloyloxyoctyl] hydrogen phosphate, bis[9-(meth)acryloyloxynonyl] hydrogen phosphate, bis[10-(meth)acryloyloxydecyl] hydrogen phosphate, 1,3-bis(meth)acryloyloxypropyl dihydrogen phosphate, 2-(meth)acryloyloxyethylphenyl hydrogen phosphate, 2-(meth)acryloyloxyethyl-2-bromoethyl hydrogen phosphate, bis[2-(meth)acryloyloxy-(1-hydroxymethyl)ethyl] hydrogen phosphate; acyl chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds.

[0032] Specific examples of polymerizable monomers having a pyrophosphate group include bis[2-(meth)acryloyloxyethyl] pyrophosphate, bis[4-(meth)acryloyloxybutyl] pyrophosphate, bis[6-(meth)acryloyloxyhexyl] pyrophosphate, bis[8-(meth)acryloyloxyoctyl] pyrophosphate, bis[10-(meth)acryloyloxydecyl] pyrophosphate; acid chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds.

[0033] Specific examples of polymerizable monomers having a thiophosphoric acid group include 2-(meth)acryloyloxyethyl dihydrogen thiophosphoric acid ester, 3-(meth)acryloyloxypropyl dihydrogen thiophosphoric acid ester, 4-(meth)acryloyloxybutyl dihydrogen thiophosphoric acid ester, 5-(meth)acryloyloxypentyl dihydrogen thiophosphoric acid ester, 6-(meth)acryloyloxyhexyl dihydrogen thiophosphoric acid ester, 7-(meth)acryloyloxyheptyl dihydrogen thiophosphoric acid ester, 8-(meth)acryloyloxyoctyl dihydrogen thiophosphoric acid ester, 9-(meth)acryloyloxybutyl dihydrogen thiophosphoric acid ester, Oxynonyl dihydrogen thiophosphate, 10-(meth)acryloyloxydecyl dihydrogen thiophosphate, 11-(meth)acryloyloxyundecyl dihydrogen thiophosphate, 12-(meth)acryloyloxydodecyl dihydrogen thiophosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen thiophosphate, 20-(meth)acryloyloxyeicosyl dihydrogen thiophosphate; acyl chlorides, alkali metal salts, ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds. It should be noted that the polymerizable monomer having a thiophosphate group can also be classified as a polymerizable monomer having a sulfur atom.

[0034] Specific examples of polymerizable monomers having a phosphonic acid group include 2-(meth)acryloyloxyethylphenylphosphonate, 5-(meth)acryloyloxypentyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonopropionate, 10-(meth)acryloyloxydecyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonoacetate, and 10-(meth)acryloyloxydecyl-3-phosphonoacetate; acid chlorides, alkali metal salts, and ammonium salts of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are substituted with amide bonds.

[0035] Specific examples of the polymerizable monomer having a sulfonic acid group include 2-(meth)acrylamide-2-methylpropanesulfonic acid and 2-sulfoethyl (meth)acrylate.

[0036] The polymerizable monomer having a carboxylic acid group is classified into a (meth)acrylic compound having one carboxyl group in the molecule and a (meth)acrylic compound having a plurality of carboxyl groups in the molecule. Specific examples of the (meth)acrylic compound having one carboxyl group in the molecule include (meth)acrylic acid, N-(meth)acryloylglycine, N-(meth)acryloylaspartic acid, O-(meth)acryloyltyrosine, N-(meth)acryloyltyrosine, N-(meth)acryloylphenylalanine, N-(meth)acryloyl-p-aminobenzoic acid, N-(meth)acryloyl-o-aminobenzoic acid, p-vinylbenzoic acid, 2-(meth)acryloyloxybenzoic acid. , 3-(meth)acryloxybenzoic acid, 4-(meth)acryloxybenzoic acid, N-(meth)acryloxy-5-aminosalicylic acid, N-(meth)acryloxy-4-aminosalicylic acid, 2-(meth)acryloxyethyl hydrogen succinate, 2-(meth)acryloxyethyl hydrogen phthalate, 2-(meth)acryloxyethyl hydrogen malate; acyl halides of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds, etc. Specific examples of the (meth)acrylic acid compound having a plurality of carboxyl groups in the molecule include 6-(meth)acryloyloxyhexane-1,1-dicarboxylic acid, 9-(meth)acryloyloxynonane-1,1-dicarboxylic acid, 10-(meth)acryloyloxydecane-1,1-dicarboxylic acid, 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, 12-(meth)acryloyloxydodecane-1,1-dicarboxylic acid, 13-(meth)acryloyloxytridecane-1,1-dicarboxylic acid, 4-(Meth)acryloyloxyethyl trimellitate, 4-(meth)acryloyloxybutyl trimellitate, 4-(meth)acryloyloxyhexyl trimellitate, 4-(meth)acryloyloxydecyl trimellitate, 2-(meth)acryloyloxyethyl-3'-(meth)acryloyloxy-2'-(3,4-dicarboxybenzoyloxy)propyl succinate; acid anhydrides and acid halides of these compounds; and (meth)acrylamide compounds in which the ester bonds of these compounds are replaced by amide bonds, etc.

[0037] Specific examples of the polymerizable monomer having an alkoxysilyl group include a (meth)acrylic compound having one alkoxysilyl group in the molecule and a (meth)acrylic compound having a plurality of alkoxysilyl groups in the molecule. Examples thereof include 2-(meth)acryloxyethyltrimethoxysilane, 3-(meth)acryloxypropyltrimethoxysilane, 3-(meth)acryloxypropyltriethoxysilane, 3-(meth)acryloxypropylmethyldimethoxysilane, 4-(meth)acryloxybutyltrimethoxysilane, 5-(meth)acryloxypentyltrimethoxysilane, 6-(meth)acryloxyhexyltrimethoxysilane, 7-(meth)acryloxyheptyltrimethoxysilane, 8-(meth)acryloxyoctyltrimethoxysilane, 9-(meth)acryloxynonyltrimethoxysilane, 10-(meth)acryloxydecyltrimethoxysilane, and 11-(meth)acryloxyundecyltrimethoxysilane.

[0038] As long as the polymerizable monomer having a sulfur atom is a polymerizable monomer having one or more sulfur atoms and a polymerizable group, a known compound can be used without any limitation. Specifically, it refers to a compound having a partial structure such as -SH, -SS-, >C=S, >CSC<, >P=S, or a compound having the above structure by tautomerism. As specific examples, 10-methacryloyloxydecyl-6,8-dithiooctanoate, 6-methacryloyloxyhexyl-6,8-dithiooctanoate, 6-methacryloyloxyhexyl 2-thiouracil-5-carboxylate, 2-(11-methacryloyloxyundecylthio)-5-mercapto-1,3,4-thiadiazole, and 10-(meth)acryloyloxydecyl dihydrogen thiophosphate can be cited.

[0039] In addition to these polymerizable monomers, there is no restriction even if an oligomer or prepolymer having at least one polymerizable group is used in the molecule. In addition, there is no problem even if a substituent such as a fluoro group is present in the same molecule. The polymerizable monomers described above can be used alone or in combination.

[0040] The dental photocurable composition of the present invention may contain a known polymerizable monomer containing an acidic group as (A) a polymerizable monomer to impart adhesion to tooth structure and prosthetic devices. Preferably, it is 10-methacryloyloxydecyl dihydrogen phosphate or 6-methacryloyloxyhexyl phosphonoacetate. From the viewpoint of imparting adhesion, the amount of the polymerizable monomer containing an acidic group is 1 part by mass or more, more preferably 10 parts by mass or more, relative to 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

[0041] In the dental photocurable composition of the present invention, in order to impart adhesion to glass ceramics, a silane coupling agent can be contained as (A) polymerizable monomer. As long as it is a known silane coupling agent, it can be used without restriction, but preferably 3-methacryloxypropyltrimethoxysilane, 8-methacryloxyoctyltrimethoxysilane, 11-methacryloxyundecyltrimethoxysilane. From the viewpoint of imparting adhesion, relative to the total amount of 100 parts by mass of the polymerizable monomer in the composition, it is more than 1 part by mass, more preferably more than 10 parts by mass and less than 20 parts by mass. Since the purpose of the silane coupling agent as a polymerizable monomer is to impart adhesion to a resin material or the like of a filler comprising glass ceramics or composed of glass ceramics, it is necessary to separately match with the surface treatment agent of the filler.

[0042] In order to impart adhesion to precious metals, the dental photocurable composition of the present invention may contain a polymerizable monomer having a sulfur atom as the (A) polymerizable monomer. From the viewpoint of imparting adhesion, the amount of the polymerizable monomer having a sulfur atom is 0.01 parts by mass or more, more preferably 0.1 parts by mass or more and less than 10 parts by mass, relative to 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

[0043] <Photopolymerization initiator>

[0044] The photopolymerization initiator used in the dental photocurable composition of the present invention includes (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, and these are not particularly limited, and commonly used known compounds can be used without any limitation.

[0045] [(B) Photosensitizer]

[0046] Specific examples of the (B) photosensitizer that can be used in the present invention include benzyl, camphorquinone, camphorquinone carboxylic acid, camphorquinone sulfonic acid, α-naphthyl, naphthyl acetone, p,p'-dimethoxybenzyl, p,p'-dichlorobenzyl acetyl, pentanedione, 1,2-phenanthrenequinone, 1,4-phenanthrenequinone, 3,4-phenanthrenequinone, 9,10-phenanthrenequinone, naphthoquinone and other α-diketones; benzoin, benzoin methyl ether, benzoin ethyl ether and other benzoin alkyl ethers; thioxanthones such as thioxanthone, 2-chlorothioxanthone, 2-methylthioxanthone, 2-isopropylthioxanthone, 2-methoxythioxanthone, 2-hydroxythioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropylthioxanthone; benzophenones such as benzophenone, p-chlorobenzophenone, p-methoxybenzophenone;Bis(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis(2,6-dimethoxybenzoyl)(2,4,4-trimethylpentyl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-n-butylphosphine oxide, bis(2,6-dimethoxybenzoyl)-(2-methylprop-1-yl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-(1-methylprop-1-yl)phosphine oxide, bis(2,6-dimethoxybenzoyl)-tert-butylphosphine oxide, bis(2,6-dimethoxybenzoyl)cyclohexylphosphine oxide, bis(2,6-dimethoxybenzoyl)octylphosphine oxide, bis(2-methoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2-methoxybenzoyl) bis(2,6-diethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,6-diethoxybenzoyl)(1-methylprop-1-yl)phosphine oxide, bis(2,6-diethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,6-dibutoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,4-dimethoxybenzoyl)(2-methylprop-1-yl)phosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)(2,4-dipentyloxyphenyl)phosphine oxide, bis(2,6-dimethoxybenzoyl)benzylphosphine oxide, bis(2,6-dimethoxybenzoyl) Acylphosphine oxides such as bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, bis(2,6-dimethoxybenzoyl)benzylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, 2,6-dimethoxybenzoylbenzylbutylphosphine oxide, 2,6-dimethoxybenzoylbenzyloctylphosphine oxide, bis(2,4,6-trimethylbenzoyl)isobutylphosphine oxide and 2,6-dimethoxybenzoyl-2,4,6-trimethylbenzoyl-n-butylphosphine oxide, bisbenzoyldiethylgermanium, bisbenzoyldimethylgermanium ...bis(2,6-dimethoxybenzoyl)-2-phenylpropylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2-phenylethylphosphine oxide, 2,6-dimethoxybenzoylbenzylbutylphosphine oxide, 2,6-dimethoxybenzoyl Acylgermanium compounds such as benzoyldibutylgermanium, bis(4-methoxybenzoyl)dimethylgermanium and bis(4-methoxybenzoyl)diethylgermanium, α-aminoacetophenones such as 2-benzyl-dimethylamino-1-(4-morpholinylphenyl)-butanone-1, 2-benzyl-diethylamino-1-(4-morpholinylphenyl)-acetone-1, ketals such as benzyl dimethyl ketal, benzyl diethyl ketal, benzyl (2-methoxyethyl ketal), titanium ocenes such as bis(cyclopentadienyl)-bis〔2,6-difluoro-3-(1-pyrrolyl)phenyl〕-titanium, bis(cyclopentadienyl)-bis(pentafluorophenyl)-titanium, bis(cyclopentadienyl)-bis(2,3,5,6-tetrafluoro-4-dimethylsiloxyphenyl)-titanium, etc. ;

[0047] (B) The photosensitizer can be appropriately selected according to the wavelength, intensity, and light irradiation time of light used for polymerization, and the types and amounts of other components combined. The photosensitizer can be used alone or in combination of two or more.

[0048] [(B-1) α-Diketone compounds]

[0049] The dental photopolymerizable composition of the present invention contains (B-1) an α-diketone compound as (B) a photosensitizer. By using (B-1) an α-diketone compound in combination with (C) a photoacid generator and (D) a photopolymerization accelerator, free radical polymerization is carried out when light is irradiated. At this time, when the amount of the (B-1) α-diketone compound is as low as 0.15 parts by mass or less relative to 100 parts by mass of the total amount of polymerizable monomers contained in the dental photocurable composition, 0.5 parts by mass or more of the (C) photoacid generator is added, and at the same time, the (D) photopolymerization accelerator is added, and free radical polymerization is carried out, it is found that sufficient mechanical strength to withstand dental use is expressed. In addition, by adding the (B-1) α-diketone compound, the hue of the dental photocurable composition before curing is yellow, but since the amount of the (B-1) α-diketone compound in the dental photocurable composition of the present invention is less than that in the past, the yellowness of the dental photocurable composition before curing is also reduced. Therefore, even in the case where the hue of the (B-1) α-diketone compound changes after free radical polymerization, the color difference is reduced due to the small amount of compounding. Therefore, it becomes easy for the surgeon who discharges the paste, etc. to imagine the hue after curing, and the risk of error in hue selection can be expected to be reduced. Since the amount of (B-1) α-diketone compound compounded is the necessary minimum, even if the dental photocurable composition filled deep into the cavity is unevenly cured, the color difference before and after curing is small and high hue consistency can be expected. In addition, since the amount of (B-1) α-diketone compound compounded, which causes the light color stability to deteriorate, is small, it can be expected that high light color stability can be obtained without a large amount of ultraviolet absorbers.

[0050] Examples of α-diketone compounds include benzyl, camphorquinone, camphorquinone carboxylic acid, camphorquinone sulfonic acid, α-naphthyl, naphthyl acetone, p,p'-dimethoxybenzyl, p,p'-dichlorobenzyl acetyl, pentanedione, 1,2-phenanthrenequinone, 1,4-phenanthrenequinone, 3,4-phenanthrenequinone, 9,10-phenanthrenequinone, naphthoquinone, etc. Among them, camphorquinone compounds such as camphorquinone, camphorquinone carboxylic acid, and camphorquinone sulfonic acid are preferred, and camphorquinone is particularly preferred.

[0051] The dental photocurable composition of the present invention contains 0.15 parts by mass or less of (B-1) α-diketone compounds relative to 100 parts by mass of the total amount of (A) polymerizable monomers contained in the composition. Preferably, it is 0.005 to 0.15 parts by mass, more preferably 0.01 to 0.15 parts by mass, and further preferably 0.05 to 0.12 parts by mass. In the case of more than 0.15 parts by mass, the color difference before and after curing becomes larger. When it is more than 0.005 parts by mass, sufficient mechanical properties can be reliably expressed. In addition, a plurality of (B-1) α-diketone compounds can be used in combination.

[0052] The dental photocurable composition of the present invention may contain only (B-1) α-diketone compounds as (B) photosensitizers. When (B) photosensitizers other than (B-1) α-diketone compounds are contained, the amount is preferably 0.001 to 1.0 parts by mass relative to 100 parts by mass of the total amount of (A) polymerizable monomers. Since the (B) photosensitizers having strong absorption between the wavelengths of 400 to 500 nm of the light source widely used in dental applications often have a strong yellow tint, 0.001 to 0.2 parts by mass is further preferred. On the other hand, the (B) photosensitizers having no strong absorption at 400 to 500 nm often have a weak yellow tint, and 0.001 to 0.5 parts by mass is further preferred. In addition, there are cases where the (B) photosensitizers do not have photobleaching ability. In this case, even when the amount of (B) photosensitizer added is large, the color tone difference before and after curing (difference in b*) does not increase, but since the yellowness of the composition before and after curing increases, when applied to a repair site where white is particularly preferred, the color tone consistency may deteriorate or the ambient light stability may decrease. Among (B) photosensitizers with strong absorption between 400 and 500 nm, there is a significant tendency for the yellowness to increase. Since (B-1) α-diketone compounds represented by camphorquinone have good photobleaching ability, they are preferred because the color tone derived from (B-1) α-diketone compounds is reduced. In addition, since the sensitization effect on photoacid generators is also high, they are preferred compared to (B) photosensitizers other than (B-1) α-diketone compounds.

[0053] [(C) Photoacid generator]

[0054] The (C) photoacid generator used in the dental photocurable composition of the present invention can use known compounds without limitation. Specifically, triazine compounds, iodonium salt compounds, sulfonium salt compounds, sulfonate compounds, etc. can be cited. Among them, triazine compounds and iodonium salt compounds are preferred because of their high polymerizability when used in combination with a sensitizer. More preferred are iodonium salt compounds. Ionium salt compounds are easily sensitized by photosensitizers that absorb in the visible light region.

[0055] Specific examples of the triazine compound include 2,4,6-tris(trichloromethyl)-s-triazine, 2,4,6-tris(tribromomethyl)-s-triazine, 2-methyl-4,6-bis(trichloromethyl)-s-triazine, 2-methyl-4,6-bis(tribromomethyl)-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methylthiophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(tribromomethyl)-s-triazine, trichloromethyl)-s-triazine, 2-(2,4-dichlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-bromophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis(trichloromethyl)-s-triazine, 2-n-propyl-4,6-bis(trichloromethyl)-s-triazine, 2-(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-s-triazine, 2-phenylvinyl-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-methoxyphenyl)vinyl]-4 , 6-bis(trichloromethyl)-s-triazine, 2-[2-(o-methoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-butoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4-dimethoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4,5-trimethoxyphenyl)vinyl]-4,6-bis(trichloromethyl)-s-triazine, 2-(1-naphthyl)-4,6-bis(trichloromethyl)-s-triazine , 2-(4-biphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N,N-bis(2-hydroxyethyl)amino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-ethylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-methylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N,N-diallylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine. Among them, 2,4,6-tris(trichloromethyl)-s-triazine is preferred.

[0056] As the iodonium salt compound, any known compound can be used. As a specific example, the structural formula of the iodonium salt compound can be represented by the following formula (1).

[0057] [(R1)2I] + [A] - Formula (1)

[0058] ([(R1)2I] +is the cationic part, [A] - is an anion part, R1 shown in formula (1) represents an organic group bonded to I, and R1 is the same or different. For example, R1 represents an aryl group having 6 to 30 carbon atoms, a heterocyclic group having 4 to 30 carbon atoms, an alkyl group having 1 to 30 carbon atoms, an alkenyl group having 2 to 30 carbon atoms, or an alkynyl group having 2 to 30 carbon atoms, and these groups may be substituted by at least one selected from the group consisting of alkyl, hydroxy, alkoxy, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, arylthiocarbonyl, acyloxy, arylthio, alkylthio, aryl, heterocyclic, aryloxy, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, alkyleneoxy, amino, cyano, nitro, etc., and halogen.)

[0059] Examples of the aryl group having 6 to 30 carbon atoms include monocyclic aryl groups such as phenyl and condensed polycyclic aryl groups such as naphthyl, anthracenyl, phenanthrenyl, pyrenyl, chrysenyl, naphthacenyl, benzanthryl, anthraquinolyl, fluorenyl, naphthoquinone and anthraquinone.

[0060] Examples of the heterocyclic group having 4 to 30 carbon atoms include cyclic substances containing 1 to 3 heteroatoms such as oxygen, nitrogen, and sulfur, and these heteroatoms may be the same or different. Specific examples include monocyclic heterocyclic groups such as thienyl, furanyl, pyranyl, pyrrolyl, oxazolyl, thiazolyl, pyridyl, pyrimidinyl, and pyrazinyl, and indolyl, benzofuranyl, isobenzofuranyl, benzothienyl, isobenzothienyl, quinolyl, isoquinolyl, quinoxalinyl, and quinazoline. Condensed polycyclic heterocyclic groups include benzophenone, carbazolyl, acridinyl, phenothiazinyl, phenazinyl, xanthenyl, thianthrenyl, phenoxazinyl, phenoxathiol, chromanyl, isochromanyl, dibenzothiophenyl, xanthonyl, thioxanthonyl, and dibenzofuranyl.

[0061] Specific examples of the alkyl group having 1 to 30 carbon atoms include straight-chain alkyl groups such as methyl, ethyl, propyl, butyl, hexadecyl and octadecyl; branched-chain alkyl groups such as isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, tert-pentyl and isohexyl; and cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

[0062] Specific examples of the alkenyl group having 2 to 30 carbon atoms include straight-chain or branched alkenyl groups such as vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl and 1-methyl-1-propenyl.

[0063] Specific examples of the alkynyl group having 2 to 30 carbon atoms include linear or branched alkynyl groups such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-1-propynyl and 1-methyl-2-propynyl.

[0064] The above-mentioned aryl group having 6 to 30 carbon atoms, heterocyclic group having 4 to 30 carbon atoms, alkyl group having 1 to 30 carbon atoms, alkenyl group having 2 to 30 carbon atoms or alkynyl group having 2 to 30 carbon atoms may or may not have at least one substituent. Specific examples of the substituent include straight-chain alkyl groups having 1 to 18 carbon atoms, such as methyl, ethyl, propyl, butyl and octadecyl groups; branched-chain alkyl groups having 1 to 18 carbon atoms, such as isopropyl, isobutyl, sec-butyl and tert-butyl groups; cycloalkyl groups having 3 to 18 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl groups; hydroxyl groups; straight-chain or branched alkyl groups having 1 to 18 carbon atoms, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy and dodecyloxy groups; branched alkoxy; straight-chain or branched alkylcarbonyl having 2 to 18 carbon atoms, such as acetyl, propionyl, butyryl, 2-methylpropionyl, heptanoyl, 2-methylbutyryl, 3-methylbutyryl, octanoyl; arylcarbonyl having 7 to 11 carbon atoms, such as benzoyl and naphthoyl; straight-chain or branched alkoxycarbonyl having 2 to 19 carbon atoms, such as methoxycarbonyl, ethoxycarbonyl, propyloxycarbonyl, isopropyloxycarbonyl, butoxycarbonyl, isobutyloxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl; aryloxycarbonyl having 7 to 11 carbon atoms, such as phenoxycarbonyl and naphthoxycarbonyl; arylthiocarbonyl having 7 to 11 carbon atoms, such as phenylthiocarbonyl and naphthoxythiocarbonyl; acetoxy, ethylcarbonyloxy, propylcarbonyloxy, isobutylcarbonyloxy, sec-butylcarbonyloxy, tert-butyl a phenylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group, a methylthio group a linear or branched alkylthio group having 1 to 18 carbon atoms, such as neopentylthio and dodecylthio; an aryl group having 6 to 10 carbon atoms, such as phenyl, tolyl, xylyl and naphthyl; a heterocyclic group having 4 to 20 carbon atoms, such as thienyl, furanyl, pyranyl, xanthyl, chromanyl, isochromanyl, xanthone, thioxanthone and dibenzofuranyl; an aryloxy group having 6 to 10 carbon atoms, such as phenoxy and naphthoxy; a linear or branched alkylsulfinyl group having 1 to 18 carbon atoms, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, tert-amylsulfinyl and octylsulfinyl; an arylsulfinyl group having 6 to 10 carbon atoms, such as phenylsulfinyl, tolylsulfinyl and naphthylsulfinyl;Straight-chain or branched alkylsulfonyl groups having 1 to 18 carbon atoms, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, and octylsulfonyl; arylsulfonyl groups having 6 to 10 carbon atoms, such as phenylsulfonyl, tolylsulfonyl (toluenesulfonyl), and naphthylsulfonyl; alkyleneoxy groups; cyano groups; nitro groups; halogens such as fluorine, chlorine, bromine, and iodine;

[0065] Among iodonium salt compounds, aryl iodonium salts are preferred due to their high stability. In addition, in order to improve fat solubility, it is preferred that the aryl group has a substituent. Specifically, a linear alkyl group such as methyl, propyl, octyl, decyl, undecyl, dodecyl, tridecyl, or a branched alkyl group such as isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, tert-pentyl, isohexyl, or a functional group in which one or more H in these groups is replaced by F, or a perfluoroalkyl group, a halogen, or the like is preferably used as a substituent.

[0066] There is no particular limitation on the structure of the anion part of the iodonium salt-based compound. For example, structures with atoms such as halogen, P, S, B, Al, and Ga can be cited. From the viewpoint of safety, anions with As or Sb can be used, but are not preferred in dental applications. In addition, the anion preferably has organic groups such as alkyl and / or alkoxy and / or aryl, and most preferably has organic groups such as alkyl and / or alkoxy and / or aryl substituted with at least one H by F. Since the iodonium salt-based compound with such an anion has high solubility in the photocurable composition, it is expected to prevent precipitation during low temperature storage or long-term storage, and to shorten the manufacturing time by dissolving in the composition in a short time. In addition, the iodonium salt-based compound composed of anions of organic groups such as alkyl and / or alkoxy and / or aryl substituted with one or more H by F can expect higher solubility. In the case of precipitation of the photoacid generator, it is not preferred because there is a reduction in light color stability or a reduction in bending strength. For such anions having organic groups such as alkyl and / or alkoxy and / or aryl groups in which at least one H may be substituted with F, anions having any atoms can be used, but from the viewpoint of versatility and safety, substances having P, S, B, Al, and Ga are preferred.

[0067] Examples of anions not having an alkyl group and / or an alkoxy group and / or an aryl group include halogens such as chlorides and bromides, perhalogen acids such as perchloric acid, aromatic sulfonic acids such as p-toluenesulfonate, camphorsulfonic acid, nitrates, acetates, chloroacetates, carboxylates, phenolates, tetrafluoroborate, hexafluorophosphate, hexafluoroantimonate, hexafluoroarsenate, etc. Among them, p-toluenesulfonate, camphorsulfonic acid, and carboxylates are preferably used.

[0068] Since the iodonium salt compound of formula (1) [A] -The anion part improves the solubility in the photopolymerizable composition, and therefore preferably has an organic group such as an alkyl group and / or an alkoxy group and / or an aryl group in which at least one H is replaced by F. Specifically, the iodonium salt compound of formula (1) [A] - The preferred carbon number of the alkyl group in the anion part is 1 to 8, preferably 1 to 4. Specific examples include straight-chain alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, and octyl; branched-chain alkyl groups such as isopropyl, isobutyl, sec-butyl, and tert-butyl; cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The ratio of the number of hydrogen atoms to fluorine atoms (F / H) in the alkyl group is 4 or more, and the ratio of the number of hydrogen atoms to fluorine atoms (F / H) in the alkyl group is preferably 9 or more. It is further preferred that all hydrogen atoms of the hydrocarbon are substituted by fluorine. Ionium salts composed of anions of alkyl groups having different ratios of hydrogen atoms to fluorine atoms can also be incorporated into the photocurable composition.

[0069] In addition, specific examples of the alkyl group include linear or branched perfluoroalkyl groups such as CF3, CF3CF2, (CF3)2CF, CF3CF2CF2, CF3CF2CF2CF2, (CF3)2CFCF2, CF3CF2(CF3)CF, and (CF3)3C.

[0070] [A] of the iodonium salt compound of formula (1) - The preferred carbon number of the alkoxy group in the anion part is 1 to 8, preferably 1 to 4. As specific examples, straight-chain alkoxy groups such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, octyloxy, or branched alkoxy groups such as isopropoxy, isobutoxy, sec-butoxy, tert-butoxy can be cited. The ratio of the number of hydrogen atoms to fluorine atoms in the alkyl group (F / H) is 4 or more, and the ratio of the number of hydrogen atoms to fluorine atoms in the alkyl group (F / H) is preferably 9 or more. It is further preferred that all hydrogen atoms of the hydrocarbon are substituted by fluorine. Ionium salts composed of anions having alkoxy groups with different ratios of hydrogen atoms to fluorine atoms can also be incorporated into the photocurable composition.

[0071] In addition, specific examples of alkoxy groups include linear or branched perfluoroalkoxy groups such as CF3O, CF3CF2O, CF3CF2CF2O, (CF3)2CFO, CF3CF2CF2CF2O, (CF3)2CFCF2O, CF3CF2(CF3)CFO, CF3CF2CF2CF2CF2O, CF3CF2CF2CF2CF2CF2O, and CF3CF2CF2CF2CF2CF2CF2CF2CF2O.

[0072] In the iodonium salt compound of formula (1), [A] -The phenyl group of the anion part has at least one hydrogen atom substituted by a fluorine atom and / or an alkyl group and / or an alkoxy group substituted by a fluorine atom. The alkyl group and / or the alkoxy group substituted by a fluorine atom are preferably the above-mentioned groups. As a specific example of a particularly preferred phenyl group, pentafluorophenyl (C6F5), trifluorophenyl (C6H2F3), tetrafluorophenyl (C6HF4), trifluoromethylphenyl (CF3C6H4), bis (trifluoromethyl)phenyl ((CF3)2C6H3), pentafluoroethylphenyl (CF3CF2C6H4), bis (pentafluoroethyl)phenyl ((CF3CF2)2C6H3), trifluoromethylfluorophenyl (CF3C6H3F), bis trifluoromethylfluorophenyl ((CF3)2C6H2F), pentafluoroethylfluorophenyl (CF3CF2C6H3F), bis pentafluoroethylfluorophenyl ((CF3CF2)2C6H2F) and other perfluorophenyl groups can be cited. The photocurable composition may further contain an iodonium salt composed of an anion having a phenyl group having a different ratio of hydrogen atoms to fluorine atoms.

[0073] [A] as the iodonium salt compound of formula (1) - Specific examples of anions having P include [(CF3CF2)3PF3] - 、[(CF3CF2CF2)3PF3] - 、[((CF3)2CF)2PF4] - 、[((CF3)2CF)3PF3] - 、[((CF3)2CF)4PF2] - 、[((CF3)2CFCF2)2PF4] - 、[((CF3)2CFCF2)3PF3] - etc. Anions containing S include [(CF3SO2)3C] - 、[(CF3CF2SO2)3C] - 、[(CF3CF2CF2SO2)3C] - 、[(CF3CF2CF2CF2SO2)3C] - , [CF3CF2CF2CF2SO3] - , [CF3CF2CF2SO3] - 、[(CF3CF2SO2)3C] - 、[(SO2CF3)3N] - 、[(SO2CF2CF3)2N] - 、[((CF3)C6H4)SO3] - 、[SO3((CF2CF2CF2CF2)SO3] 2-As anion having B, [B(C6F5)4] - 、[(C6H5)B(C6F5)3] - 、[(C6H5)B((CF3)2C6H3))3] - As anions containing Ga, [((CF3)4Ga) - 、[Ga(C6F5)4] - As anions containing Al, [((CF3)3CO)4Al] - 、[((CF3CF2)3CO)4Al] - wait.

[0074] The dental photocurable composition of the present invention may contain only an aryl iodonium salt as (C) a photoacid generator. The dental photocurable composition of the present invention may contain only an aryl iodonium salt as (C) a photoacid generator, which is a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation. The dental photocurable composition of the present invention may contain only an organic group having at least one H substituted with F and an anion having one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation as (C) a photoacid generator.

[0075] The dental photocurable composition of the present invention contains 0.5 parts by mass or more of (C) a photoacid generator relative to the total amount of 100 parts by mass of the polymerizable monomer (A). The preferred amount is 0.5 to 10 parts by mass, and more preferably 1 to 5 parts by mass. When the amount of the photoacid generator is less than 0.5 parts by mass, the polymerization promoting ability may be lacking and the curing may be insufficient. When more than 10 parts by mass are added, although the curing property is sufficient, the ambient light stability is shortened and the cured body has an increased discoloration such as brown or yellow, so it is not preferred.

[0076] The photoacid generator that can be used in the dental photocurable composition of the present invention is not limited to the photoacid generators shown in the specific examples, and two or more types of photoacid generators can be used in combination.

[0077] [(D) Photopolymerization accelerator]

[0078] The (D) photopolymerization accelerator used in the dental photocurable composition of the present invention is not particularly limited as long as it has the ability to promote polymerization, and any known photopolymerization accelerator commonly used in the dental field can be used without any restriction. As the photopolymerization accelerator, primary to tertiary amine compounds such as aromatic amine compounds and aliphatic amine compounds, organic metal compounds, phosphine compounds, etc. can be used. Among them, aliphatic tertiary amine compounds and organic metal compounds are preferred because of their excellent light color stability.

[0079] An aromatic amine compound refers to a compound in which one or more H of ammonia (NH3) is substituted with an aromatic ring. A compound in which one H of NH3 is substituted with an aromatic ring can be classified as an aromatic primary amine compound, a compound in which one H of NH3 is substituted with an aromatic ring and one different H is substituted with an aromatic ring or an alkyl group can be classified as an aromatic secondary amine compound, and a compound in which one H of NH3 is substituted with an aromatic ring and two different Hs are substituted with aromatic rings or an alkyl group can be classified as an aromatic tertiary amine compound.

[0080] Specific examples of the aromatic primary amine compound include aniline, etc. Specific examples of the aromatic secondary amine compound include N-phenylbenzylamine, N-benzyl-p-anisidine, N-benzyl-o-aminophenylethyl ether, N-phenylglycine ethyl ester, N-phenylglycine such as N-protected amino acids (esters), etc. Specific examples of the aromatic tertiary amine compound include N,N-dimethylaniline, N,N-diethylaniline, N,N-di-n-butylaniline, N,N-dimethyl-p-toluidine, N,N-dimethyl-m-toluidine, N,N-diethyl-p-toluidine, p-bromo-N,N-dimethylaniline, m-chloro-N,N-dimethylaniline. , p-dimethylaminobenzaldehyde, p-dimethylaminoacetophenone, p-dimethylaminobenzoic acid, ethyl p-dimethylaminobenzoate, isopentyl p-dimethylaminobenzoate, 2-butoxyethyl p-dimethylaminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, amino p-dimethylaminobenzoate, methyl N,N-dimethyl anthranilate, N,N-dihydroxyethylaniline, N,N-dihydroxyethyl p-toluidine, p-dimethylaminophenyl alcohol, p-dimethylaminostyrene, N,N-dimethyl-3,5-dimethylaniline, 4-dimethylaminopyridine, N,N-dimethyl-α-naphthylamine, N,N-dimethyl-β-naphthylamine, etc.

[0081] Specific examples of the above-mentioned organic metal compounds include organic metal compounds containing scandium (Sc), titanium (Ti), vanadium (V), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), tin (Sn), zinc (Zn), and zirconium (Zr), preferably organic metal compounds containing tin (Sn), vanadium (V), and copper (Cu). Specific examples of the organometallic compound containing tin (Sn) include dibutyltin diacetate, dibutyltin dimaleate, dioctyltin dimaleate, dioctyltin dilaurate, dibutyltin dilaurate, dioctyltin ditert-carbonate, S,S'-dioctyltin diisooctylthioacetate, tetramethyl-1,3-diacetoxydistannoxane, etc. Specific examples of the organometallic compound containing vanadium (V) include vanadium acetylacetonate, vanadium tetroxide, vanadium acetylacetonate, vanadium oxide stearate, vanadium oxalate, vanadium sulfate, di(1-phenyl-1,3-butanedione)oxyvanadium, bis(maltol)oxyvanadium, vanadium pentoxide, sodium metavanadate, etc. Specific examples of the organometallic compound containing copper (Cu) include copper acetylacetonate, copper naphthenate, copper octoate, copper stearate, and copper acetate.

[0082] The phosphine compound refers to a compound in which an organic group is trisubstituted on the P atom, and the aromatic phosphine compound refers to a compound in which a phenyl group is substituted and which may or may not have one or more substituents on the P atom. Specific examples of the phosphine compound include trimethylphosphine, tributylphosphine, trihexylphosphine, tri-n-octylphosphine, tricyclohexylphosphine, tri(2-thienyl)phosphine, diphenylpropylphosphine, di-tert-butyl(3-methyl-2-butenyl)phosphine, methyldiphenylphosphine, triphenylphosphine, 2-(diphenylphosphino)styrene, 3-(diphenylphosphino)styrene, 4-(diphenylphosphino)styrene, allyldiphenylphosphine, 2-(diphenylphosphino)benzaldehyde, 3-(diphenylphosphino)benzaldehyde, 4-(diphenylphosphino)benzaldehyde, 2-(phenylphosphino)benzoic acid ... 1-(phenylphosphino)benzoic acid, 4-(phenylphosphino)benzoic acid, tri(2-methoxyphenyl)phosphine, tri(3-methoxyphenyl)phosphine, tri(4-methoxyphenyl)phosphine, 2-(diphenylphosphino)biphenyl, tri(4-fluorophenyl)phosphine, tri(o-tolyl)phosphine, tri(m-tolyl)phosphine, tri(p-tolyl)phosphine, 2-(dimethylamino)phenyldiphenylphosphine, 3-(dimethylamino)phenyldiphenylphosphine, 4-(dimethylamino)phenyldiphenylphosphine, 2,2'-bis(diphenylphosphino)biphenyl, bis[2-(diphenylphosphino)phenyl]ether, etc. Among them, triphenylphosphine, 4-(phenylphosphino)benzoic acid, tri(o-tolyl)phosphine, tri(m-tolyl)phosphine, and tri(p-tolyl)phosphine are preferred.

[0083] Aliphatic amine compounds refer to compounds in which one or more H of ammonia (NH3) is replaced by an alkyl group. For alkyl groups, CH3- or -CH2- is classified as a primary alkyl group, an alkyl group in which one H of -CH2- is substituted is classified as a secondary alkyl group, and an alkyl group in which two H of -CH2- are substituted is classified as a tertiary alkyl group. For aliphatic amines, an aliphatic amine in which one H of NH3 is substituted by an alkyl group is classified as an aliphatic primary amine compound, an aliphatic amine in which two H of NH3 are substituted by an alkyl group is classified as an aliphatic secondary amine compound, and an aliphatic amine in which three H of NH3 are substituted by an alkyl group is classified as an aliphatic tertiary amine compound.

[0084] Specific examples of aliphatic primary amine compounds include diphenylmethylamine, triphenylmethylamine, amino acids or amino acid esters such as glycine, and the like. Specific examples of aliphatic secondary amine compounds include dibenzylamine, N-benzyl-1-phenylethylamine, bis(1-phenylethyl)amine, bis(4-cyanobenzyl)amine, N-benzyl protected amino acids or N-benzyl protected amino acid esters, and specific examples of aliphatic tertiary amine compounds include tributylamine, tripropylamine, triethylamine, N,N-dimethylhexylamine, N,N-dimethyldodecylamine, N,N-dimethylstearylamine, N-[ 3-(dimethylamino)propyl] acrylamide, N,N-dimethylformamide dimethyl acetal, N,N-dimethylacetamide dimethyl acetal, N,N-dimethylformamide diethyl acetal, N,N-dimethylformamide dipropyl acetal, N,N-dimethylformamide di-tert-butyl acetal, 1-(2-hydroxyethyl)ethyleneimine, N,N-dimethylethanolamine, N,N-dimethylisopropanolamine, N,N-diisopropylethanolamine, N-methyldiethanolamine, N-ethyldiethanolamine, N-ethyldiethanolamine, N-butyldiethanolamine, N-lauryldiethanolamine Ethanolamine, N-stearyl diethanolamine, triethanolamine, tribenzylamine, dibenzylglycine ethyl ester, N'-(2-hydroxyethyl)-N,N,N'-trimethylethylenediamine, 2-(dimethylamino)-2-methyl-1-propanol, N,N-dimethyl-2,3-dihydroxypropylamine, N,N-diethylethanolamine, 1-methyl-3-pyrrolidinol, 1-(2-hydroxyethyl)pyrrolidine, 1-isopropyl-3-pyrrolidinol, 1-piperidinol, 2-[2-(dimethylamino)ethoxy]ethanol, N,N-dimethylglycine, N,N-dimethyl N,N-diethylglycine methyl ester, N,N-dimethylglycine ethyl ester, N,N-diethylglycine sodium, 2-(dimethylamino)ethyl acetate, N-methyliminodiacetic acid, N,N-dimethylaminoethyl acrylate, N,N-diethylaminoethyl methacrylate, N,N-dibutylaminoethyl methacrylate, N,N-dibenzylaminoethyl methacrylate, 3-dimethylaminopropionitrile, tris(2-cyanoethyl)amine, N,N-dimethylallylamine, N,N-diethylallylamine, triallylamine, etc.

[0085] (D) It is particularly preferred to use an aliphatic tertiary amine compound as a photopolymerization accelerator. Since the light color stability of aromatic amine compounds is poor, if used for prosthetic devices, restorative materials, and adhesives in parts that are easily irradiated by light such as front teeth, the color tone sometimes changes over time, and is therefore not preferred. In addition, by using a UV absorber in combination, it is possible to expect to suppress the discoloration caused by light over time. However, UV absorbers are used as common additives, so it is not possible to expect the improvement of mechanical properties brought about by the combination, and there is also a situation in which the yellow tone of the dental photocurable composition before curing is increased, so it is not preferred to combine in large quantities. For these reasons, it is preferred to use an aliphatic tertiary amine compound. In addition, depending on the composition of the dental photocurable composition, high storage stability and high mechanical strength can be expected when containing an aliphatic primary amine compound and an aliphatic secondary amine compound, so known substances can be used without any restrictions.

[0086] In addition, among the aliphatic tertiary amine compounds, it is preferred that (D-1) is not an aliphatic tertiary amine compound having two or more primary hydroxyl groups in the molecule, that is, (D-1) is an aliphatic tertiary amine compound not having two or more primary hydroxyl groups, and it is further preferred that it is an aliphatic tertiary amine compound not having a primary hydroxyl group in the molecule. Specific examples of aliphatic tertiary amine compounds having two or more primary hydroxyl groups in the molecule include triethanolamine, methyldiethanolamine, etc. Specific examples of aliphatic tertiary amine compounds (D-1) not having two or more primary hydroxyl groups include N,N-dimethylethanolamine, N,N-diethylethanolamine, N,N-dibenzylethanolamine, etc. Since a low-boiling point compound such as N,N-dimethylethanolamine and N,N-diethylethanolamine is added in large amounts, a peculiar odor of amines is generated, and therefore, among the aforementioned specific examples, N,N-dibenzylethanolamine is preferred. As specific examples of aliphatic tertiary amine compounds that do not have a primary hydroxyl group in the molecule, tribenzylamine, N,N-dibenzylglycine ethyl ester, dimethylaminoethyl methacrylate, diethylaminoethyl methacrylate, etc. can be cited. When the cured body of the dental photocurable composition is stored for a long time, the amine compound having a primary hydroxyl group may become the cause of discoloration. There is a tendency for the discoloration to increase as the number of primary hydroxyl groups in the molecule increases, and it becomes particularly significant when there are two or more in the molecule. By storing it under the conditions of high temperature water, the discoloration during long-term storage of the cured body can be confirmed in a short time. There is less discoloration under the conditions of high temperature water, that is, when the thermal color stability is high, the discoloration of the cured body of the dental photocurable composition is small during long-term use.

[0087] The dental photocurable composition of the present invention may contain only aliphatic tertiary amine compounds as (D) photopolymerization accelerators. The dental photocurable composition of the present invention may contain only (D-1) aliphatic tertiary amine compounds not having two or more primary hydroxyl groups as (D) photopolymerization accelerators. The dental photocurable composition of the present invention may contain only aliphatic tertiary amine compounds not having primary hydroxyl groups in the molecule as (D) photopolymerization accelerators.

[0088] The (D) photopolymerization accelerator preferably contains 0.1 to 20 parts by mass, more preferably 0.1 to 10 parts by mass, and most preferably 0.5 to 10 parts by mass relative to 100 parts by mass of the total amount of the (A) polymerizable monomer contained in the dental photopolymerizable composition. In the case of less than 0.1 parts by mass, there is a case where the mechanical strength is insufficient. In the case of more than 20 parts by mass, although there is sufficient curability, there is a case where the ambient light stability is shortened and the cured body has an increased discoloration such as brown or yellow, which is not preferred.

[0089] As required, there is no problem in performing secondary treatments such as fine grinding, carrier adsorption, and microcapsulation of these (B) photosensitizers, (C) photoacid generators, and (D) photopolymerization accelerators as polymerization initiators. Furthermore, regardless of the polymerization mode or polymerization method, these various photopolymerization initiators can be used alone or in combination of two or more.

[0090] [(E) Filler]

[0091] As the filler (E) used in the present invention, any commonly used known filler can be used without limitation.

[0092] The type of filler (E) is not limited as long as it is a known filler, and can be mixed with fillers according to its use, preferably with fillers such as inorganic fillers, organic fillers or organic-inorganic composite fillers. These fillers can be used not only alone, but also in combination with multiple types regardless of the type of filler.

[0093] As the above-mentioned inorganic filler, there is no particular limitation on their chemical composition, and specific examples thereof include silica, alumina, silica-titania, silica-titania-barium oxide, silica-zirconium oxide, silica-alumina, lanthanum glass, borosilicate glass, soda glass, barium glass, strontium glass, glass ceramics, aluminosilicate glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, aluminum fluorosilicate glass, calcium aluminum fluorosilicate glass, strontium aluminum fluorosilicate glass, barium aluminum fluorosilicate glass, strontium calcium aluminum fluorosilicate glass, etc. In particular, barium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, and fluoroaluminosilicate glass, etc., which are used for dental glass ionomer cement, resin reinforced glass ionomer cement, and resin cement, etc., can also be preferably used. The fluoroaluminosilicate glass described herein has silica and alumina as the basic skeleton and includes an alkali metal for introducing non-crosslinking oxygen. Furthermore, it has alkaline earth metals including strontium as modifying / coordinating ions and fluorine. In addition, in order to further impart X-ray opacity, it is a composition in which a lanthanide element is incorporated into the framework. The lanthanide element is also incorporated into the composition as a modifying / coordinating ion depending on the composition domain.

[0094] Specific examples of the organic filler include polymers such as polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, ethyl methacrylate-butyl methacrylate copolymer, methyl methacrylate-trimethylolpropane methacrylate copolymer, polyvinyl chloride, polystyrene, chlorinated polyethylene, nylon, polysulfone, polyethersulfone, and polycarbonate.

[0095] Examples of organic-inorganic composite fillers include composite fillers obtained by coating the surface of a filler with a polymerizable monomer, composite fillers obtained by mixing a filler and a polymerizable monomer, polymerizing the mixture, and then crushing the mixture into an appropriate particle size, or composite fillers obtained by preliminarily dispersing the filler in a polymerizable monomer and then performing emulsion polymerization or suspension polymerization, but the present invention is not limited to these composite fillers.

[0096] In order to improve the affinity with polymerizable monomers, the dispersibility in polymerizable monomers, the mechanical strength and water resistance of the cured body, the above-mentioned (E) filler can be treated with a surface treatment material represented by a silane coupling agent. This surface treatment material and surface treatment method are not particularly limited, and known methods can be adopted without restriction. As the silane coupling agent for the surface treatment of the filler, preferably methyltrimethoxysilane, methyltriethoxysilane, methyltrichlorosilane, dimethyldichlorosilane, trimethylchlorosilane, vinyltrichlorosilane, vinyltriethoxysilane, vinyltri(2-methoxyethoxy)silane, 3-methacryloxypropyltrimethoxysilane, 3-chloropropyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-(methyl)acryloxypropyltrimethoxysilane, 8-(methyl)acryloxyoctyltrimethoxysilane, 11-(methyl)acryloxyundecyltrimethoxysilane or hexamethyldisilazane etc. In addition, the surface treatment of the filler can be carried out by using a titanate coupling agent or an aluminate coupling agent in addition to a silane coupling agent. The treatment amount of the surface treatment material in the filler is preferably 0.01 to 30 parts by mass, more preferably 0.5 to 20 parts by mass, relative to 100 parts by mass of the filler before treatment.

[0097] The shape of the filler is not particularly limited, and fillers of any shape such as amorphous, spherical, needle-shaped, plate-shaped, crushed, flaky, etc. can be used. In addition, the average particle size of the filler is preferably 0.2 μm to 50 μm, more preferably 0.2 μm to 30 μm, further preferably 0.2 μm to 20 μm, and further preferably 0.2 μm to 10 μm.

[0098] The dental photocurable composition of the present invention contains 100 parts by mass or more of (E) filler relative to 100 parts by mass of the total amount of (A) polymerizable monomers. Compared with the case where the (E) filler is 100 parts by mass or more, the proportion of the (B) α-diketone compound in the dental photocurable composition increases when the (E) filler is less than 100 parts by mass, so there is a case where the color difference before and after curing increases. In the case where the dental photocurable composition is a single-dose type, the (E) filler is 150 parts by mass or more, preferably 1000 parts by mass or less. Since the paste state of the composition becomes hard when more than 1000 parts by mass are combined, there is a case where the processing becomes difficult, but there is also a case where more than 1000 parts by mass are included depending on the type of filler or the surface treatment conditions of the filler. For example, it refers to the case where the filler has a high specific gravity, the case where the amount of the surface treatment agent for the filler is large, the case where a surface treatment agent with good affinity for the polymerizable monomer is used, etc. When the dental photocurable composition is a two-part composition, the amount of the filler (E) is preferably 200 parts by mass or more and 800 parts by mass or less based on a total of 200 parts by mass of the (A) polymerizable monomer contained in the first base constituting the first paste and the second base constituting the second paste.

[0099] The dental photocurable composition of the present invention may contain a chemical polymerization initiator. Organic peroxides as chemical polymerization initiators include diacyl peroxides, peroxyesters, dialkyl peroxides, peroxyketals, ketone peroxides, peroxydicarbonates, and hydroperoxides. Specific examples of diacyl peroxides include acetyl peroxide, isobutyryl peroxide, benzoyl peroxide, decanoyl peroxide, 3,5,5-trimethylhexanoyl peroxide, 2,4-dichlorobenzoyl peroxide, and lauroyl peroxide. Specific examples of the peroxyesters include α-cumyl peroxyneodecanoate, t-butyl peroxyneodecanoate, t-butyl peroxypivalate, 2,2,4-trimethylpentyl peroxy-2-ethylhexanoate, t-amyl peroxy-2-ethylhexanoate, t-butyl peroxy-2-ethylhexanoate, di-t-butyl peroxyisophthalate, di-t-butyl peroxyhexahydroterephthalate, t-butyl peroxy-3,3,5-trimethylhexanoate, t-butyl peroxyacetate, t-butyl peroxybenzoate, and t-butyl peroxymaleate. Specific examples of dialkyl peroxides include di-tert-butyl peroxide, dicumyl peroxide, tert-butyl cumyl peroxide, 2,5-dimethyl-2,5-di(tert-butylperoxy)hexane, 1,3-bis(tert-butylperoxyisopropyl)benzene, and 2,5-dimethyl-2,5-di(tert-butylperoxy)-3-hexyne. Specific examples of peroxyketals include 1,1-di(tert-butylperoxy)cyclohexane, 2,2-di(tert-butylperoxy)butane, n-butyl 4,4-(tert-butylperoxy)valerate, and 1,1-di(tert-amylperoxy)cyclohexane. Specific examples of ketone peroxides include methyl ethyl ketone peroxide, methyl isobutyl ketone peroxide, methylcyclohexanone peroxide, and cyclohexanone peroxide. Specific examples of peroxydicarbonates include di-3-methoxy peroxydicarbonate, di-2-ethylhexyl peroxydicarbonate, bis(4-tert-butylcyclohexyl) peroxydicarbonate, diisopropyl peroxydicarbonate, di-n-propyl peroxydicarbonate, di-2-ethoxyethyl peroxydicarbonate, and diallyl peroxydicarbonate. Specific examples of hydroperoxides include 2,5-dimethylhexane-2,5-dihydroperoxide, diisopropylbenzene hydroperoxide, cumene hydroperoxide, tert-butyl hydroperoxide, and 1,1,3,3-tetramethylbutyl hydroperoxide.

[0100] For organic peroxide, the above-mentioned organic peroxide can be used alone or two or more organic peroxides can be used in combination. Among these organic peroxides, from the viewpoint of curability, preferably benzoyl peroxide and cumene hydroperoxide. From the viewpoint of improving curability, relative to the total amount 100 mass parts of (A) polymerizable monomers, the organic peroxide as a chemical polymerization initiator is preferably set to 0.1~5 mass parts, and further preferably set to 0.3~3 mass parts. In addition, if the amount of organic peroxide is more than 5 mass parts, it is sometimes difficult to fully ensure the operating time. On the other hand, if the amount of organic peroxide is less than 0.1 mass part, the mechanical strength is sometimes insufficient.

[0101] In order to improve the curability, a chemical polymerization accelerator may be added to the dental photocurable composition of the present invention. Examples of the chemical polymerization accelerator include transition metal compounds of the fourth period, thiourea derivatives, aliphatic amines, aromatic amines, sulfinic acid and its salts, borate compounds, sulfur-containing reducing inorganic compounds, nitrogen-containing reducing inorganic compounds, barbituric acid derivatives, triazine compounds, halogen compounds, etc. The amount of the chemical polymerization accelerator is preferably 0.01 to 5 parts by mass, more preferably 0.1 to 3 parts by mass, relative to 100 parts by mass of the total amount of the polymerizable monomers.

[0102] The transition metal compound of the 4th period as a chemical polymerization accelerator refers to a metal compound of Groups 3 to 12 of the 4th period of the periodic table. Specifically, as long as it is a metal compound of scandium (Sc), titanium (Ti), vanadium (V), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), and zinc (Zn), it can be used without limitation. In addition, each of the above-mentioned transition metal elements can take multiple valences, but as long as it is a valence that can exist stably, it can be added to the dental photocurable composition of the present invention. For example, Sc (3 valence), Ti (4 valence), V (3, 4 or 5 valence), Cr (2, 3 or 6 valence), Mn (2 to 7 valence), Fe (2 or 3 valence), Co (2 or 3 valence), Ni (2 valence), Cu (1 or 2 valence), Zn (2 valence). Specific examples of transition metal compounds include scandium iodide (trivalent) and the like as scandium compounds, titanium chloride (quadrivalent) and tetraisopropoxytitanium (quadrivalent) and the like as titanium compounds, and vanadium acetylacetonate (trivalent), vanadium tetroxide (quadrivalent), vanadium acetylacetonate (quadrivalent), vanadium oxide stearate (quadrivalent), vanadium oxalate (quadrivalent), vanadium sulfate (quadrivalent), di(1-phenyl-1,3-butanedione)oxyvanadium (quadrivalent), bis(maltol)oxyvanadium (quadrivalent), vanadium pentoxide (quinavalent), sodium metavanadate (quinavalent) and the like as vanadium compounds. Examples of manganese compounds include manganese acetate (divalent), manganese naphthenate (divalent), etc. Examples of iron compounds include iron acetate (divalent), iron chloride (divalent), iron acetate (trivalent), iron chloride (trivalent), etc. Examples of cobalt compounds include cobalt acetate (divalent), cobalt naphthenate (divalent), etc. Examples of nickel compounds include nickel chloride (divalent), etc. Examples of copper compounds include copper chloride (monovalent), copper bromide (monovalent), copper chloride (divalent), copper acetate (divalent), etc. Examples of zinc compounds include zinc chloride (divalent), zinc acetate (divalent), etc.

[0103] Among them, trivalent or tetravalent vanadium compounds and divalent copper compounds are preferred, wherein trivalent or tetravalent vanadium compounds with higher polymerization promoting ability are more preferred, and tetravalent vanadium compounds are most preferred. These transition metal compounds of the 4th period can be used in combination as needed. Relative to 100 parts by mass of the total amount of (A) polymerizable monomers, the amount of the transition metal compound is preferably 0.0001 to 1 part by mass, and when it is less than 0.0001 parts by mass, the polymerization promoting effect is sometimes insufficient, and when it is greater than 1 part by mass, discoloration or gelation of the dental photocurable composition is caused, and storage stability is sometimes reduced.

[0104] As the thiourea derivative of chemical polymerization accelerator, as long as it is a known thiourea derivative, it can be used without restriction. As a specific example, dimethylthiourea, diethylthiourea, tetramethylthiourea, (2-pyridyl) thiourea, N-methylthiourea, ethylenethiourea, N-allylthiourea, N-allyl-N'-(2-hydroxyethyl) thiourea, N-benzylthiourea, 1,3-dicyclohexylthiourea, N, N'-diphenylthiourea, 1,3-di(p-tolyl)thiourea, 1-methyl-3-phenylthiourea, N-acetylthiourea, N-benzoylthiourea, diphenylthiourea, dicyclohexylthiourea, etc. are enumerated. Among them, preferably (2-pyridyl) thiourea, N-acetylthiourea, N-benzoylthiourea. These thiourea derivatives can be used in combination in multiples as needed. The amount of the thiourea derivative is preferably 0.1 to 5 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A). When it is less than 0.1 parts by mass, the polymerization promoting ability may be insufficient, and when it is more than 5 parts by mass, the storage stability may be reduced.

[0105] Examples of the sulfinic acid and its salt include p-toluenesulfinic acid, sodium p-toluenesulfinic acid, potassium p-toluenesulfinic acid, lithium p-toluenesulfinic acid, calcium p-toluenesulfinic acid, benzenesulfinic acid, sodium benzenesulfinic acid, potassium benzenesulfinic acid, lithium benzenesulfinic acid, calcium benzenesulfinic acid, 2,4,6-trimethylbenzenesulfinic acid, sodium 2,4,6-trimethylbenzenesulfinic acid, potassium 2,4,6-trimethylbenzenesulfinic acid, lithium 2,4,6-trimethylbenzenesulfinic acid, calcium 2,4,6-trimethylbenzenesulfinic acid, 2,4,6-triethylbenzenesulfinic acid, 2,4 , 6-triethylbenzenesulfinate sodium, 2,4,6-triethylbenzenesulfinate potassium, 2,4,6-triethylbenzenesulfinate lithium, 2,4,6-triethylbenzenesulfinate calcium, 2,4,6-triisopropylbenzenesulfinic acid, 2,4,6-triisopropylbenzenesulfinate sodium, 2,4,6-triisopropylbenzenesulfinate potassium, 2,4,6-triisopropylbenzenesulfinate lithium, 2,4,6-triisopropylbenzenesulfinate calcium, etc., particularly preferably sodium benzenesulfinate, sodium p-toluenesulfinate, 2,4,6-triisopropylbenzenesulfinate sodium.

[0106] Specific examples of borate compounds having one aromatic group in one molecule include trialkylphenylborane, trialkyl(p-chlorophenyl)borane, trialkyl(p-fluorophenyl)borane, trialkyl(3,5-bistrifluoromethyl)phenylborane, trialkyl[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, trialkyl(p-nitrophenyl)borane, trialkyl(m-nitrophenyl)borane, trialkyl(p-butylphenyl)borane, trialkyl(m-butylphenyl)borane, The invention also includes sodium salts, lithium salts, potassium salts, magnesium salts, tetrabutylammonium salts, tetramethylammonium salts, tetraethylammonium salts, methylpyridinium salts, ethylpyridinium salts, butylpyridinium salts, methylquinolinium salts, ethylquinolinium salts, butylquinolinium salts, and the like of trialkyl(p-butoxyphenyl)boron, trialkyl(m-butoxyphenyl)boron, trialkyl(p-octyloxyphenyl)boron and trialkyl(m-octyloxyphenyl)boron (the alkyl group is at least one selected from the group consisting of n-butyl, n-octyl and n-dodecyl, etc.). Specific examples of the borate compound having two aromatic groups in one molecule include dialkyldiphenylborane, dialkyldi(p-chlorophenyl)borane, dialkyldi(p-fluorophenyl)borane, dialkyldi(3,5-bistrifluoromethyl)phenylborane, dialkyldi[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, dialkyldi(p-nitrophenyl)borane, dialkyldi(m-nitrophenyl)borane, dialkyldi(p-butylphenyl)borane, dialkyldi(m-butylphenyl)borane, The invention also includes sodium salts, lithium salts, potassium salts, magnesium salts, tetrabutylammonium salts, tetramethylammonium salts, tetraethylammonium salts, methylpyridinium salts, ethylpyridinium salts, butylpyridinium salts, methylquinolinium salts, ethylquinolinium salts and butylquinolinium salts of dialkyldi(p-butoxyphenyl)boron, dialkyldi(m-butoxyphenyl)boron, dialkyldi(p-octyloxyphenyl)boron and dialkyldi(m-octyloxyphenyl)boron (the alkyl group is at least one selected from n-butyl, n-octyl and n-dodecyl groups, etc.). Specific examples of the borate compound having three aromatic groups in one molecule include monoalkyl triphenylborane, monoalkyl tri(p-chlorophenyl)borane, monoalkyl tri(p-fluorophenyl)borane, monoalkyl tri(3,5-bistrifluoromethyl)phenylborane, monoalkyl tri[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borane, monoalkyl tri(p-nitrophenyl)borane, monoalkyl tri(m-nitrophenyl)borane, monoalkyl tri(p-butylphenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl) ...(3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, monoalkyl tri(3,5-bis(trifluoromethyl)phenyl)borane, mono Sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, butylquinolinium salt, etc. of (m-butylphenyl)boron, monoalkyltri(p-butoxyphenyl)boron, monoalkyltri(m-butoxyphenyl)boron, monoalkyltri(p-octyloxyphenyl)boron and monoalkyltri(m-octyloxyphenyl)boron (the alkyl group is one selected from n-butyl, n-octyl or n-dodecyl, etc.).Specific examples include borate compounds having four aromatic groups in one molecule, such as tetraphenylboron, tetrakis(p-chlorophenyl)boron, tetrakis(p-fluorophenyl)boron, tetrakis(3,5-bistrifluoromethyl)phenylboron, tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, tetrakis(p-nitrophenyl)boron, tetrakis(m-nitrophenyl)boron, tetrakis(p-butylphenyl)boron, tetrakis(m-butylphenyl)boron, tetrakis(p-butoxyphenyl)boron, tetrakis(m-butoxyphenyl)boron, tetrakis(p-octyloxyphenyl)boron. , sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt and butylquinolinium salt of tetrakis(m-octyloxyphenyl)boron, (p-fluorophenyl)triphenylboron, (3,5-bistrifluoromethyl)phenyltriphenylboron, (p-nitrophenyl)triphenylboron, (m-butoxyphenyl)triphenylboron, (p-butoxyphenyl)triphenylboron, (m-octyloxyphenyl)triphenylboron and (p-octyloxyphenyl)triphenylboron, etc.

[0107] Among these aryl borate compounds, from the viewpoint of storage stability, it is more preferable to use a borate compound having three or four aryl groups in one molecule. In addition, these aryl borate compounds can be used alone or in combination of two or more.

[0108] Examples of the sulfur-containing reducing inorganic compound include sulfites, bisulfites, pyrosulfites, thiosulfates, thionates, dithionites, and the like. Specific examples include sodium sulfite, potassium sulfite, calcium sulfite, ammonium sulfite, sodium bisulfite, potassium bisulfite, 3-mercaptopropyltrimethoxysilane, 2-mercaptobenzoxazole, decanethiol, and thiobenzoic acid.

[0109] Examples of the nitrogen-containing reducing inorganic compound include nitrites, and specific examples thereof include sodium nitrite, potassium nitrite, calcium nitrite, and ammonium nitrite.

[0110] Examples of the barbituric acid derivatives include barbituric acid, 1,3-dimethylbarbituric acid, 1,3-diphenylbarbituric acid, 1,5-dimethylbarbituric acid, 5-butylbarbituric acid, 5-ethylbarbituric acid, 5-isopropylbarbituric acid, 5-cyclohexylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1,3-dimethyl-5-ethylbarbituric acid, 1,3-dimethyl-n-butylbarbituric acid, 1,3-dimethyl-5-isobutylbarbituric acid, 1,3-dimethylbarbituric acid, 1,3-dimethyl-5-cyclopentylbarbituric acid, 1,3-dimethyl-5-cyclohexylbarbituric acid, 1,3-dimethyl-5-phenylbarbituric acid, 1-cyclohexyl-1-ethylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, 5-methylbarbituric acid, 5-propylbarbituric acid, 1,5-diethylbarbituric acid, 1-ethyl-5-methylbarbituric acid, 1-ethyl-5-isobutylbarbituric acid, 1,3-diethyl-5-butylbarbituric acid, 1-cyclohexyl-5-methylbarbituric acid, 1-cyclohexyl-5-ethylbarbituric acid, 1-cyclohexyl-5-octylbarbituric acid, 1-cyclohexyl-5-hexylbarbituric acid, 5-butyl-1-cyclohexylbarbituric acid, 1-benzyl-5-phenylbarbituric acid and salts of thiobarbituric acids (preferably alkali metals or alkaline earth metals). Specific examples of the salts of these barbituric acids include sodium 5-butylbarbiturate, sodium 1,3,5-trimethylbarbiturate and sodium 1-cyclohexyl-5-ethylbarbiturate.

[0111] Specific examples of the halogen compound include dilauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride, benzyltrimethylammonium chloride, tetramethylammonium chloride, benzyldimethylcetylammonium chloride, and dilauryldimethylammonium bromide.

[0112] The dental photocurable composition of the present invention may not contain a chemical polymerization initiator and a chemical polymerization accelerator. The photocurable composition of the present invention may not contain a polymerization initiator system of a polymerization system other than a photopolymerization system.

[0113] <Other ingredients>

[0114] In addition, the dental photocurable composition of the present invention may contain components other than the components (A) to (D) as long as the effect of the present invention is not inhibited. For example, benzophenone-based and benzotriazole-based ultraviolet absorbers, hydroquinone, hydroquinone monomethyl ether, 2,5-di-tert-butyl-4-methylphenol and other polymerization inhibitors; α-alkyl styrene compounds, n-butyl mercaptan, n-octyl mercaptan and other thiol compounds; limonene, myrcene, α-terpinene, β-terpinene, γ-terpinene, terpinene, β-pinene, α-pinene and other terpenoid compounds and other chain transfer agents; aminocarboxylic acid chelating agents, phosphonic acid chelating agents and other metal scavenging materials; discoloration inhibitors, antibacterial agents, coloring pigments, water and solvents that can be mixed with water at any ratio, other conventionally known additives and other components can be added as needed.

[0115] When the dental photocurable composition of the present invention contains a colorant such as a pigment, the change in color tone before and after curing may be reduced in appearance compared to when no colorant is contained. However, in any case, the change in color tone before and after curing is smaller than that of conventional photopolymerization initiators, so it can be expected that sufficient mechanical properties can be expressed in dental applications.

[0116] The method for preparing the dental photocurable composition of the present invention is not particularly limited. As a general method for producing the dental photocurable composition, there can be cited a method in which a matrix is ​​prepared in advance by mixing (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, and (D) a photopolymerization accelerator, the matrix is ​​kneaded with a filler (E), and bubbles are removed under vacuum to prepare a uniform paste. In the present invention, the above-mentioned production method can be used to produce without any problem.

[0117] The dental photocurable composition of the present invention can be used as a dental adhesive material, a dental composite resin, a dental abutment repair material, a dental resin cement, a dental coating material, a dental pit and fissure sealing material, a dental cosmetic material, a dental loose tooth fixing adhesive material, a dental hard resin, a dental cutting material, and a dental 3D printing material.

[0118] The dental photocurable composition of the present invention preferably has a b* before curing when the dental photocurable composition (when the dental photocurable composition contains a pigment, the dental photocurable composition excluding the pigment) is colorimetrically measured on a white background with a thickness of 1 mm in the L*a*b* space, and a b* before curing when the cured body of the dental photocurable composition is colorimetrically measured on a white background with a thickness of 1 mm, which is less than 4. In the present invention, after filling a stainless steel mold (15φ×1mm: disk-shaped) with the dental photocurable composition, a colorless, transparent cover glass with a thickness of less than 170μm is placed from the top and pressed with a glass plate, and after confirming that the dental photocurable composition is in a uniform state without bubbles, the colorimetric measurement of the color before curing is performed. Next, the cover glass was cured by irradiating light for 1 minute using a photopolymerization irradiator (Griplight II: manufactured by Matsukaze). After the cured product was taken out of the mold, the color tone of the test body was measured as the color tone after curing. The test body was placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38) and the color was measured using a spectrocolorimeter (manufactured by BYK Chemicals) under prescribed conditions (light source: C, viewing angle: 2°, measurement area: 11 mm).

[0119] <One-component dental photocurable composition>

[0120] When the present invention is used in a single-component dental photocurable composition, it is preferably used as a dental material for dental bonding materials, dental composite resins, dental abutment building materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing bonding materials, dental hard resins, dental cutting materials, and dental 3D printing materials, and is particularly preferably used for dental bonding materials, dental composite resins, dental abutment building materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing bonding materials, and dental hard resins. In the case of a single-component dental photocurable composition, it can be expected that there are few technical errors and a reduced risk of bubble mixing.

[0121] <Two-component dental photocurable composition>

[0122] When the present invention is used for a two-component dental photocurable composition, in particular, it is preferably used as a dental material for dental adhesives, dental composite resins, dental abutment construction materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixed adhesives, dental hard resins, dental cutting materials, and dental 3D printing materials, and is particularly preferably used for dental adhesives, dental composite resins, dental abutment construction materials, and dental resin cements. The two-component dental material is used by kneading two reagents divided into a first paste and a second paste just before use. The first paste and the second paste are kneaded in a volume ratio of 0.9 to 1.1:1.0 or a mass ratio of 0.8 to 1.2:1.0, preferably in an equal volume ratio. The kneading method can be performed by a dedicated oscillating device or manual kneading using a scraper, etc., automatic kneading by a static mixer, and other known methods. Since the components can be divided into two doses, compounds that cannot be formulated in the same paste can be formulated separately, and thus the storage stability is excellent.

[0123] The dental photocurable composition of the present invention may contain only (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler. In addition, as components other than (A) to (E), only one or more of the above components may be contained.

[0124] [Example]

[0125] Hereinafter, examples of the present invention will be described in detail, but the present invention is not limited to these examples.

[0126] The materials and their abbreviations used in Examples and Comparative Examples are as follows.

[0127] [(A) Polymerizable Monomer]

[0128] Bis-GMA: 2,2-bis[4-(3-methacryloyloxy-2-hydroxypropoxy)phenyl]propane.

[0129] D2.6E: 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane having an average added ethoxy group mole number of 2.6.

[0130] UDMA: N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)ethanol]methacrylate.

[0131] TEGDMA: triethylene glycol dimethacrylate.

[0132] NPG: neopentyl glycol dimethacrylate.

[0133] MDP: 10-methacryloyloxydecyl dihydrogen phosphate.

[0134] MHPA: 6-methacryloyloxyhexylphosphonoacetate.

[0135] [(B) Photosensitizers other than (B-1) α-diketones]

[0136] BAPO: phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide.

[0137] [(B-1) α-Diketones]

[0138] CQ: Camphorquinone.

[0139] CQ-COOH: camphorquinonecarboxylic acid.

[0140] [(C) Photoacid generator]

[0141] <Salts of anions having an organic group and at least one atom of P, B, Al, S, or Ga and aryliodonium cations>

[0142] C1: bis(4-tert-butylphenyl)iodonium p-toluenesulfonate.

[0143]

[0144] C2: bis(4-tert-butylphenyl)iodonium camphorsulfonate.

[0145]

[0146] <Salt of an organic group having one or more H atoms replaced by F and an anion of one or more atoms of P, B, Al, S, and Ga and an aryliodonium cation>

[0147] C3: bis(4-tert-butylphenyl)iodonium nonafluorobutane sulfonate.

[0148]

[0149] C4: bis(4-tert-butylphenyl)iodonium tris(pentafluoropropyl)trifluorophosphate.

[0150]

[0151] C5: p-cumyl(p-tolyl)iodonium tris(pentafluoroethyl)trifluorophosphate.

[0152]

[0153] C6: bis(4-tert-butylphenyl)iodonium tetrakis(nonafluoro-tert-butoxy)aluminate.

[0154]

[0155] C7: di-p-tolyliodonium phenyl tris(pentafluorophenyl)borate.

[0156]

[0157] C8: bis(4-tert-butylphenyl)iodonium tris(trifluoromethanesulfonyl)methide.

[0158]

[0159] C9: bis(4-tert-butylphenyl)iodonium-o-trifluoromethylbenzenesulfonate.

[0160]

[0161] C10: bis(bis(4-tert-butylphenyl)iodonium)octafluorobutane disulfonate.

[0162]

[0163] C11: bis[4-(tert-butyl)phenyl]iodonium tetrakis(pentafluorophenyl)gallate.

[0164]

[0165] C12: bis(4-n-dodecylphenyl)iodonium tetrakis(pentafluorophenyl)borate.

[0166]

[0167] <Photoacid generator other than a salt of an anion having an organic group and an aryliodonium cation> C13: bis(4-tert-butylphenyl)iodonium hexafluorophosphate.

[0168]

[0169] C14: 2,4,6-Tris(trichloromethyl)-1,3,5-triazine.

[0170]

[0171] C15: diphenyliodonium-2-carboxylate monohydrate.

[0172]

[0173] [(D) Photopolymerization accelerator]

[0174] <Aliphatic tertiary amine>

[0175] <<Aliphatic tertiary amine compound having no primary hydroxyl group>>

[0176] TBA: tribenzylamine.

[0177] DBGE: N,N-dibenzylglycine ethyl.

[0178] DEAEMA: N,N-diethylaminoethyl methacrylate.

[0179] DMAEMA: N,N-dimethylaminoethyl methacrylate.

[0180] <<Aliphatic tertiary amine compound having one primary hydroxyl group>>

[0181] DBAE: N,N-dibenzylaminoethanol.

[0182] <<Aliphatic tertiary amine compound having two primary hydroxyl groups>>

[0183] MDEOA: methyldiethanolamine.

[0184] <<Aliphatic tertiary amine compound having three primary hydroxyl groups>>

[0185] TEA: triethanolamine.

[0186] <Aromatic tertiary amine compounds>

[0187] DMBE: N,N-dimethylaminobenzoic acid ethyl ester.

[0188] DEPT: N,N-dihydroxyethyl-p-toluidine.

[0189] DMPT: N,N-dimethyl-p-toluidine.

[0190] <Organometallic compounds>

[0191] DBTL: dibutyltin dilaurate.

[0192] [(E) Filler]

[0193] The production method of each filler used for preparing the dental photocurable composition is as follows.

[0194] (Padding 1)

[0195] A silane coupling treatment liquid obtained by stirring 50.0 g of water, 35.0 g of ethanol, and 3.0 g of 3-methacryloxypropyltrimethoxysilane as a silane coupling agent at room temperature for 2 hours was added to 100.0 g of fluoroaluminosilicate glass (average particle size 0.9 μm), and stirred and mixed for 30 minutes. Thereafter, a heat treatment was performed at 100° C. for 15 hours to obtain a filler 1.

[0196] (Padding 2)

[0197] A silane coupling treatment liquid was added to 100.0 g of a zirconium silicate filler (average particle size 0.8 μm: 85 wt% zirconium oxide, 15 wt% silicon dioxide), and stirred for 30 minutes. The silane coupling treatment liquid was obtained by stirring 50.0 g of water, 35.0 g of ethanol, and 5.0 g of 3-methacryloxypropyltrimethoxysilane as a silane coupling agent at room temperature for 2 hours. Thereafter, a heat treatment was performed at 100° C. for 15 hours to obtain a filler 2.

[0198] [Chemical polymerization initiator]

[0199] CHP: cumene hydroperoxide.

[0200] BPO: Benzoyl peroxide.

[0201] [Chemical polymerization accelerator]

[0202] PTU: (2-pyridyl)thiourea.

[0203] DEPT: N,N-dihydroxyethyl-p-toluidine.

[0204] DMPT: N,N-dimethyl-p-toluidine.

[0205] COA: Copper acetylacetonate.

[0206] VOA: Vanadyl acetylacetonate.

[0207] [Ultraviolet light absorber]

[0208] BT: 2-(2-hydroxy-5-methylphenyl)benzotriazole.

[0209] [Polymerization inhibitor]

[0210] BHT: 2,6-di-tert-butyl-4-methylphenol.

[0211] MeHQ: p-methoxyphenol.

[0212] [Fluorescent agent]

[0213] FA: diethyl 2,5-dihydroxyterephthalate.

[0214] <Method for producing a one-component dental photocurable composition>

[0215] All the components except the filler (E) shown in Table 1 were put into a wide-mouth plastic container and mixed for 48 hours using a mixing rotor VMRC-5 at 100 rpm to obtain a matrix. Thereafter, the matrix and the filler (E) were put into a kneader, and after being uniformly stirred, they were degassed under vacuum to prepare a dental photocurable composition. It should be noted that the content (parts by mass) of each component in the table is represented by the numerical value in the brackets after the abbreviation of each component.

[0216] [Table 1]

[0217]

[0218] <Method for producing two-component dental photocurable composition>

[0219] All the ingredients except (E) filler shown in Table 2 are put into a wide-mouth plastic container and mixed for 48 hours at 100rpm using a mixing rotor VMRC-5 to obtain a matrix. Thereafter, the matrix and (E) filler are put into a kneader, and after uniform stirring, the pastes 1 and 2 are obtained by degassing under vacuum, and then the first paste and the second paste are filled in a double syringe (5mL) made by a mixing packaging company (Mikspark) to prepare a dental light-curable composition. When in use, a paste is mixed with the first paste and the second paste using a mixing tip made by a mixing packaging company. The mixing tip made by the mixing packaging company can be mixed by a static mixer, and in the case of using it, the first paste and the second paste can be kneaded in a volume ratio of 0.9 to 1.1: 1.00, and ideally, can be kneaded in equal volumes. The first paste and the second paste are kneaded and used in a manner of 0.8 to 1.2: 1.0 in terms of mass ratio conversion. In addition, the content (mass parts) of each component in the table is represented by the numerical value in the brackets after the abbreviation of each component.

[0220] [Table 2]

[0221]

[0222] The test methods used in the examples and comparative examples are as follows: The one-component dental photocurable composition was directly collected, and the two-component dental photocurable composition was prepared by mixing the first paste and the second paste using a mixing head manufactured by Mixpack.

[0223] (1) Bending strength

[0224] After filling the prepared dental photocurable composition into a stainless steel mold, cover glasses are placed on both sides and crimped with a glass adjustment plate, and then light irradiation is performed at 5 locations for 10 seconds each for curing using a photopolymerization irradiator (Pen Bright: made by Matsukaze). After curing, after removing the cured product from the mold, the back side is also light irradiated again in the same manner to prepare a test body (25×2×2mm: rectangular). For a single-component dental photocurable composition, a bending test is performed after the test body is immersed in water at 37°C for 24 hours. For a two-component dental photocurable composition, a bending test is performed within 1 hour of light irradiation of the bent test body. A bending test is performed using an Instron universal testing machine (made by Instron) with a fulcrum distance of 20mm and a crosshead speed of 1mm / min. The flexural strength of the one-component dental photocurable composition and the two-component dental photocurable composition was judged to be good if 100 MPa or more, usable if 80 MPa or more to less than 100 MPa, and insufficient if less than 80 MPa.

[0225] (2) Color difference before and after light curing

[0226] After filling the stainless steel mold (15φ×1mm: disc-shaped) with the prepared dental photocurable composition, a colorless, transparent cover glass with a thickness of less than 170μm was placed from the top and crimped with a glass plate. After confirming that the dental photocurable composition is in a uniform state without bubbles, the color tone before curing was measured. Next, a photopolymerization irradiator (Griplight II: made by Matsukaze) was used to irradiate light for 1 minute from the cover glass to cure it. After removing the cured product from the mold, the color tone of the test body was measured. The test body was placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38), and a spectrophotometer (made by BYK Chemical Co., Ltd.) was used to measure the color under specified conditions (light source: C, field angle: 2°, measurement area: 11mm). According to the color measurement results, the color tone difference before and after photocuring is evaluated by the values ​​of b* before curing and b* after curing. b* corresponds to blue to yellow, and the higher the b*, the greater the yellowness. Generally, since dental materials use a light source of 400 to 500nm, especially 450 to 490nm, and the photosensitizer has absorption at 400 to 500nm, the increase in b* is proportional to the amount of photosensitizer. On the other hand, when the color tone of the photosensitizer disappears after polymerization, b* decreases. In addition, since the color change in dental materials is mostly yellow or reddish brown, the color tone change can be evaluated based on the change in b*. In the present invention, the change value of b* before and after curing, that is, Δb* is less than 4, which is judged to be good, Δb* is 4 to 5, which is judged to be applicable, and Δb* is judged to be insufficient when it exceeds 5. In the case where Δb* exceeds 5, it is judged that the color tone before and after curing changes greatly, and the color tone after curing cannot be predicted from before curing. On the other hand, in the case where Δb* is less than 5, it is judged that the color tone before and after curing changes little, and the color tone after curing can be predicted from before curing. The b* after curing may be less than 7, preferably less than 6. When the b* after curing is less than 7, the material can be used in cases where the material is applied to teeth with less yellowness, and can be preferably used in white dental materials that are separately blended with white pigments such as titanium oxide.

[0227] (3) Light color stability

[0228] After filling the stainless steel mold (15φ×1mm: disc-shaped) with the prepared dental photocurable composition, a cover glass was placed from the top and pressed with a glass plate. The cover glass was irradiated with light for 1 minute using a photopolymerization irradiator (Griplight II: made by Matsukaze) to cure it. After taking out the cured product from the mold, the cover glass was removed and the color tone of the test body was measured. The test body was placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38) and the color was measured under certain conditions (light source: C, viewing angle: 2°, measurement area: 11mm) using a spectrocolorimeter (made by BYK Chemical). After that, the test body was exposed for 24 hours using a xenon lamp exposure tester (SUNTEST CPS+), and the color tone of the test body was measured again. The difference in color change was expressed by ΔE calculated by the following formula.

[0229] ΔE={(ΔL*) 2 +(Δa*) 2 +(Δb*) 2} 1 / 2

[0230] ΔL*=L1*-L2*

[0231] Δa*=a1*-a2*

[0232] Δb*=b1*-b2*

[0233] Here, L1* is the brightness index before exposure, L2* is the brightness index after exposure, a1 and b1* are the color quality indexes before exposure, and a2* and b2* are the color quality indexes after exposure. ΔE less than 5 is judged to be the best, ΔE of 5 to 10 is judged to be good, and ΔE exceeding 10 is judged to be applicable. When the light color stability is good, when the dental material is used in the oral cavity for a long time, it can be used with little discoloration and high aesthetics.

[0234] (4) Thermal color stability

[0235] After filling the stainless steel mold (15φ×1mm: disc-shaped) with the prepared dental photocurable composition, a cover glass is placed from the top and pressed with a glass plate. The cover glass is irradiated with light for 1 minute using a photopolymerization irradiator (Griplight II: made by Matsukaze) to cure it. After removing the cured product from the mold, the cover glass is removed and the color tone of the test body is measured. The test body is placed on a background of a standard white plate (D65 / 10°X=81.07, Y=86.15, Z=93.38) and a spectrophotometer (made by BYK Chemical) is used to measure the color under certain conditions (light source: C, viewing angle: 2°, measurement area: 11mm). Thereafter, the test body is immersed in a container containing 10mL of water in a thermostat set at 70°C, and after standing for one week, the color tone of the test body is measured again, and the difference in discoloration is expressed by ΔE calculated by the following formula.

[0236] ΔE={(ΔL*) 2 +(Δa*) 2 +(Δb*) 2} 1 / 2

[0237] ΔL*=L1*-L2*

[0238] Δa*=a1*-a2*

[0239] Δb*=b1*-b2*

[0240] Here, L1* is the brightness index before immersion and standing, L2* is the brightness index after immersion and standing, a1 and b1* are the color quality indexes before immersion and standing, and a2* and b2* are the color quality indexes after immersion and standing. ΔE less than 5 is judged to be the best, ΔE of 5 to 10 is judged to be good, and ΔE exceeding 10 is judged to be applicable. In the case of good thermal stability, when the dental material can be used for a long time in the oral cavity, there is little discoloration and a high aesthetic state is maintained over a long period of time.

[0241] The results shown in Tables 3 and 4 are described.

[0242] [Table 3]

[0243]

[0244] [Table 4]

[0245]

[0246] Since the composition described in the Examples has a Δb* of less than 5 and a flexural strength of 80 MPa or more, the change in color tone before and after curing is sufficiently small, and the composition has a mechanical strength sufficient to be suitable for a dental material.

[0247] Examples A1, A60, A66, and B1 have a tendency to have low bending strength due to a small amount of the α-diketone compound. On the other hand, Examples A8, A19, A50, A51, B5, and B15 have a tendency to have increased b* before and after curing due to a large amount of the α-diketone compound.

[0248] Examples A9, A60, A66, and B6 have a tendency to have low bending strength due to a small amount of the photoacid generator. On the other hand, Examples A13, A19, A51, A61, and B10 have a tendency to have poor light color stability and a tendency to increase b* after curing despite high bending strength due to a large amount of the photoacid generator.

[0249] In Examples A29 to A34 and B24 to B29, the aryl iodonium salt contained as the photoacid generator is a composition containing a compound that is not a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation. In Examples A29 to A31 and B24 to B26, in which the amount of the photoacid generator is relatively small, the bending strength is low and the light color stability tends to be slightly deteriorated. In Examples A32 to A34 and B27 to B29, in which the amount of the photoacid generator is relatively large, the light color stability tends to be further deteriorated, and the b* after curing also tends to increase. In Examples 69 and 70, in which the aryl iodonium salt contained as the photoacid generator is a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation, there is a tendency to suppress the deterioration of light color stability or the increase of b*.

[0250] The aryl iodonium salt contained in the photoacid generator of Examples A35 to A38, B31 to B34 is a composition comprising a salt of an organic group having more than one H substituted by F and an anion of any one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation. Examples A35, A36, B31, and B32, in which the amount of the photoacid generator is relatively small, tend to have low bending strength. Examples A37, A38, B33, and B34, in which the amount of the photoacid generator is relatively large, tend to have poor light color stability. Examples 69 and 70, in which the aryl iodonium salt contained in the photoacid generator is a salt of an anion of any one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation, tend to suppress the deterioration of light color stability.

[0251] Examples A14, A48, A66, and B11 have a tendency to have low bending strength due to a small amount of photopolymerization accelerator. On the other hand, Examples A18, A67, and B14 have a tendency to have poor light color stability due to a large amount of photopolymerization accelerator, and also have a tendency to have increased b* after curing.

[0252] Examples A20 to A23, A43 to A46, A52, A53, A59, A65, B34 to B37 contain aromatic amines as photopolymerization accelerators. For example, Examples A20, A21, B34, and B35 have a tendency to lack light color stability. On the other hand, when a UV absorber is added at the same time as in Examples A22 and A23, there is a tendency to suppress the deterioration of light color stability. However, when a large amount of UV absorber is added, it is preferable not to add a large amount of it because there is a possibility that it becomes a cause of b* increase or mechanical strength reduction. In addition, Example A65, which contains only 0.01 parts by mass of a trace amount of aromatic amine, has good light color stability.

[0253] Examples A24 to A26, A39 to A43, B16 to B18, and B41 to B44 contain aliphatic amines having primary hydroxyl groups. Examples A24 and B16 containing DBAE having one primary hydroxyl group in the molecule have a tendency to slightly deteriorate in thermal color stability, but are still within a particularly good range. Examples A25, A26, A39 to A43, B17, B18, and B41 to B44 containing MDEOA having two primary hydroxyl groups in the molecule and TEA having three primary hydroxyl groups in the molecule have a tendency to significantly lack thermal color stability. In addition, Examples A45, A46, B36, and B37 containing DEPT having two primary hydroxyl groups in the molecule also have a tendency to lack thermal color stability. This tendency is also present in Examples B45, B46, and B48, which are compounded as chemical polymerization accelerators, and even when compounded as chemical polymerization accelerators, they can sometimes function as photopolymerization accelerators.

[0254] Comparative Examples CA1 and CB1, which do not contain α-diketone compounds, do not show sufficient curability. Comparative Example CA11, which contains BAPO as a photosensitizer instead of α-diketone compounds, has insufficient bending strength. Comparative Examples CA2 to CA4 and Comparative Examples CB2 to CB4, which contain a large amount of α-diketone compounds, are insufficient because the Δb* before and after curing exceeds 5. Comparative Examples CA5 and CB5, which contain a small amount of photoacid generators, and Comparative Examples CA6 and CB6, which do not contain photopolymerization accelerators, have insufficient bending strength. Comparative Examples CA7 to CA10 and CB7 and CB8, which contain a small amount of filler or no filler, have no problem with curability because the bending strength is sufficiently high, but are insufficient because the Δb* before and after curing exceeds 5.

[0255] The dental photocurable composition of the present invention evaluated in the examples can be used without any problems in all known dental photocurable compositions. The dental photocurable composition refers to dental adhesives, dental composite resins, dental abutment repair materials, dental resin cements, dental coating materials, dental pit and fissure sealing materials, dental cosmetic materials, dental loose tooth fixing adhesives, dental glass ionomer cements, dental hard resins, dental cutting materials, dental 3D printing materials, etc.

[0256] In this specification, when a constituent element of the invention is described as being in the singular or plural, or when described without limitation to the singular or plural, the constituent element may be in the singular or plural unless otherwise understood from the context.

[0257] Although the present invention has been described with reference to the detailed embodiments, it should be understood by those skilled in the art that various changes or modifications can be made based on the matters disclosed in this specification. Therefore, the scope of the embodiments of the present invention is intended to include any changes or modifications.

[0258] According to the present invention, it is possible to provide a dental photocurable composition which has sufficient mechanical properties, has a small color difference before and after curing, and is excellent in color tone selectivity.

Claims

1. A dental photocurable composition comprising (A) a polymerizable monomer, (B) a photosensitizer, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler, wherein: (B) The photosensitizer comprises (B-1) an α-diketone compound, The composition comprises 0.15 parts by mass or less of (B-1) an α-diketone compound, 0.5 parts by mass or more of (C) a photoacid generator, and 100 parts by mass or more of (E) a filler, based on 100 parts by mass of the (A) polymerizable monomer. (C) The photoacid generator includes an aryliodonium salt.

2. The dental photocurable composition according to claim 1, wherein (B-1) The α-diketone compound is a camphorquinone compound.

3. The dental photocurable composition according to claim 1, wherein The aryliodonium salt is a salt of an anion having an organic group and any one or more atoms of P, B, Al, S, and Ga, and an aryliodonium cation.

4. The dental photocurable composition according to claim 1, wherein The aryl iodonium salt is a salt of an organic group having at least one H substituted by F and an anion of any one or more atoms of P, B, Al, S, and Ga and an aryl iodonium cation.

5. The dental photocurable composition according to claim 1, wherein (D) The photopolymerization accelerator includes (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.

6. The dental photocurable composition according to any one of claims 1 to 5, wherein The (C) photoacid generator is contained in an amount of 1 part by mass or more and the (D) photopolymerization accelerator is contained in an amount of 0.5 parts by mass or more, based on 100 parts by mass of the (A) polymerizable monomer.

7. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition, when the dental photocurable composition contains a pigment, refers to the dental photocurable composition excluding the pigment, and the difference between the b* before curing when measuring the color tone in the L*a*b* space on a white background with a thickness of 1 mm and the b* after curing when measuring the color tone of the cured body of the dental photocurable composition in the L*a*b* space on a white background with a thickness of 1 mm is 5 or less.

8. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition is a single-component dental photocurable composition. The composition comprises 0.005 to 0.15 parts by mass of the (B-1) α-diketone compound, 0.5 to 10 parts by mass of the (C) photoacid generator, 0.1 to 10.0 parts by mass of the (D) photopolymerization accelerator, and 150 to 1000 parts by mass of the (E) filler, based on 100 parts by mass of the (A) polymerizable monomer.

9. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition is a two-component dental photocurable composition, which is composed of a first paste and a second paste. The first paste comprises a first matrix containing (A) a polymerizable monomer, (B-1) an α-diketone compound, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler. The second paste comprises a second matrix containing (A) a polymerizable monomer, (B-1) an α-diketone compound, (C) a photoacid generator, (D) a photopolymerization accelerator, and (E) a filler. The ratio of the first paste to the second paste is 1:0.8~1.

2. Relative to 200 parts by mass of the total (A) polymerizable monomer contained in the first substrate and the second substrate, it contains 0.01 to 0.3 parts by mass of the (B-1) α-diketone compound, 1.0 to 20.0 parts by mass of the (C) photoacid generator, 0.2 to 20.0 parts by mass of the (D) photopolymerization accelerator, and 200 to 800 parts by mass of the (E) filler.

10. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition is used in combination with a dental composition for checking the uniformity of color tone to constitute a dental kit.

11. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) The polymerizable monomer includes an acidic group-containing polymerizable monomer.

12. The dental photocurable composition according to claim 11, wherein The amount of the acidic group-containing polymerizable monomer to be added is 1 part by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

13. The dental photocurable composition according to claim 11, wherein The amount of the acidic group-containing polymerizable monomer to be added is 10 parts by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

14. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) A silane coupling agent is contained as a polymerizable monomer.

15. The dental photocurable composition according to claim 14, wherein The amount of the silane coupling agent added is 1 part by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

16. The dental photocurable composition according to claim 14, wherein The amount of the silane coupling agent is 10 parts by mass or more and less than 20 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

17. The dental photocurable composition according to any one of claims 1 to 5, wherein (A) The polymerizable monomer includes a polymerizable monomer having a sulfur atom.

18. The dental photocurable composition according to claim 17, wherein The amount of the polymerizable monomer having a sulfur atom is 0.01 parts by mass or more based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

19. The dental photocurable composition according to claim 17, wherein The amount of the polymerizable monomer having a sulfur atom is 0.1 parts by mass or more and less than 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomers contained in the dental photocurable composition.

20. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the (B-1) α-diketone compound is 0.01 to 0.15 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomer.

21. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the (B-1) α-diketone compound is 0.05 to 0.12 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomer.

22. The dental photocurable composition according to any one of claims 1 to 5, wherein As the (B) photosensitizer, only the (B-1) α-diketone compound is included.

23. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the (B) photosensitizer other than the (B-1) α-diketone compound is 0.001 to 1.0 part by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomer.

24. The dental photocurable composition according to any one of claims 1 to 5, wherein (C) The photoacid generator contains only an aryliodonium salt.

25. The dental photocurable composition according to any one of claims 1 to 5, wherein (C) The photoacid generator contains only a salt of an anion having an organic group and one or more atoms of P, B, Al, S, and Ga as an aryliodonium salt and an aryliodonium cation.

26. The dental photocurable composition according to any one of claims 1 to 5, wherein (C) The photoacid generator includes a salt of an anion of an organic group having at least one H group replaced by F and at least one atom of P, B, Al, S, and Ga, and an aryliodonium cation.

27. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photoacid generator (C) blended is 0.5 to 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A).

28. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photoacid generator (C) blended is 1 to 5 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A).

29. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only aliphatic tertiary amine compounds.

30. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only (D-1) an aliphatic tertiary amine compound not having two or more primary hydroxyl groups.

31. The dental photocurable composition according to any one of claims 1 to 5, wherein (D) The photopolymerization accelerator contains only aliphatic tertiary amine compounds having no primary hydroxyl group in the molecule.

32. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photopolymerization accelerator (D) blended is 0.1 to 20 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A).

33. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photopolymerization accelerator (D) is 0.1 to 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A).

34. The dental photocurable composition according to any one of claims 1 to 5, wherein The amount of the photopolymerization accelerator (D) is 0.5 to 10 parts by mass based on 100 parts by mass of the total amount of the polymerizable monomer (A).

35. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition includes a chemical polymerization initiator.

36. The dental photocurable composition according to claim 35, wherein Chemical polymerization initiators are organic peroxides.

37. The dental photocurable composition according to claim 35, wherein The amount of the chemical polymerization initiator is 0.1 to 5 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.

38. The dental photocurable composition according to claim 35, wherein The amount of the chemical polymerization initiator is 0.3 to 3 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.

39. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition includes a chemical polymerization accelerator.

40. The dental photocurable composition according to claim 39, wherein The chemical polymerization accelerator is one or more selected from the group consisting of 4th period transition metal compounds, thiourea derivatives, aliphatic amines, aromatic amines, sulfinic acid and its salts, borate compounds, sulfur-containing reducing inorganic compounds, nitrogen-containing reducing inorganic compounds, barbituric acid derivatives, triazine compounds, and halogen compounds.

41. The dental photocurable composition according to claim 39, wherein The amount of the chemical polymerization accelerator to be added is 0.01 to 5 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomer.

42. The dental photocurable composition according to claim 39, wherein The amount of the chemical polymerization accelerator to be added is 0.1 to 3 parts by mass based on 100 parts by mass of the total amount of the (A) polymerizable monomers.

43. The dental photocurable composition according to any one of claims 1 to 5, wherein The dental photocurable composition further comprises one or more selected from a UV absorber, a polymerization inhibitor, a chain transfer agent, a metal scavenger, a discoloration inhibitor, an antibacterial agent, and a coloring pigment.